<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Late Night Pyq (Inicet, Mixed Bag-17) - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / Late Night PYQ (INICET)
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">75</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 14057,
    "choices": [
      {
        "id": 56189,
        "text": "<p><span style=\"font-size:12.0pt;\">Rough handling of thyroid during surgery</span></p>"
      },
      {
        "id": 56190,
        "text": "<p><span style=\"font-size:12.0pt;\">Due to parathyroid gland injury</span></p>"
      },
      {
        "id": 56191,
        "text": "<p><span style=\"font-size:12.0pt;\">Inadequate patient preparation</span></p>"
      },
      {
        "id": 56192,
        "text": "<p><span style=\"font-size:12.0pt;\">Infections</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the usual cause of thyroid storm in thyroidectomy? (AIIMS NOV 2018)</span></p>",
    "unique_key": "Q9231276",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449295,
    "difficulty_level": "beginner",
    "subjects_id": [
      12
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Inadequate patient preparation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Inadequate preparation of a patient with hyperthyroidism before thyroidectomy, such as not optimizing thyroid function and medication management, can increase the risk of thyroid storm. Proper preoperative management and stabilization of thyroid function are crucial to prevent this complication.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Rough handling of thyroid during surgery</strong>: While rough handling during thyroid surgery can potentially lead to complications, it is not the usual cause of thyroid storm.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Due to parathyroid gland injury</strong>: The parathyroid glands are separate from the thyroid gland and regulate calcium levels in the body. Complications involving the parathyroid glands can occur during thyroid surgery leading to postoperative hypocalcemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Infections</strong>: Infections can occur as complications after thyroid surgery, but they are not the usual cause of thyroid storm. Thyroid storm is primarily related to the excessive release of thyroid hormones into the bloodstream.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A thyroid storm, also known as thyrotoxic crisis, is a rare but life-threatening medical emergency that occurs in individuals with severe hyperthyroidism. Hyperthyroidism is a condition in which the thyroid gland produces an excessive amount of thyroid hormones, primarily thyroxine (T4) and triiodothyronine (T3). In a thyroid storm, these hormone levels become dangerously elevated, leading to a wide range of symptoms and complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Symptoms of a thyroid storm may include:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">High fever</span></li><li><span style=\"font-size:12.0pt;\">Rapid and irregular heartbeat (tachycardia)</span></li><li><span style=\"font-size:12.0pt;\">Elevated blood pressure</span></li><li><span style=\"font-size:12.0pt;\">Extreme agitation and restlessness</span></li><li><span style=\"font-size:12.0pt;\">Profuse sweating</span></li><li><span style=\"font-size:12.0pt;\">Tremors and shaking</span></li><li><span style=\"font-size:12.0pt;\">Nausea, vomiting, and diarrhea</span></li><li><span style=\"font-size:12.0pt;\">Delirium or confusion</span></li><li><span style=\"font-size:12.0pt;\">Jaundice (yellowing of the skin and eyes)</span></li><li><span style=\"font-size:12.0pt;\">Coma (in severe cases)</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thyroid storms can be triggered by various factors, such as surgery, infection, trauma, or medication changes in individuals with underlying hyperthyroidism. The condition is more common in people with Graves' disease, a common cause of hyperthyroidism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Treatment of a thyroid storm is a medical emergency and typically involves a combination of interventions to rapidly lower thyroid hormone levels, control symptoms, and support vital organ function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The usual cause of thyroid storm in thyroidectomy is inadequate patient preparation before surgery. Thus, patient preparation pre-operatively involves ensuring a euthyroid state.</span></p>",
    "correct_choice_id": 56191,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13037,
    "choices": [
      {
        "id": 52110,
        "text": "<p><span style=\"font-size:12.0pt;\">Bansdola</span></p>"
      },
      {
        "id": 52111,
        "text": "<p><span style=\"font-size:12.0pt;\">Garroting</span></p>"
      },
      {
        "id": 52112,
        "text": "<p><span style=\"font-size:12.0pt;\">Mugging</span></p>"
      },
      {
        "id": 52113,
        "text": "<p><span style=\"font-size:12.0pt;\">Throttling</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">The image below shows strangulation by Spanish windlass method. What type of strangulation method does it belong to? (INICET NOV 2022)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-37.jpg\" alt=\"\" width=\"300\" height=\"300\"></span></p>",
    "unique_key": "Q3573172",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449399,
    "difficulty_level": "beginner",
    "subjects_id": [
      10
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Garroting</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Spanish windlass</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Method:</strong> It involves tightening an iron collar (Spanish windlass) around the neck and forcing a spike against the neck into the spinal cord.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Garroting</strong>- It involves attacking the victim by throwing the ligature from behind over the victim's neck and then tightened by twisting with a lever.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Bansdola: </strong>A method of strangulation where a ligature is applied in a different manner, often using a stick or rod to twist and tighten the ligature.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Mugging: </strong>Refers to a method where the assailant uses their limbs, such as the crook of their elbow, to compress the neck.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Throttling: </strong>Throttling involves using hands to manually compress the neck, leading to asphyxia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Spanish windlass method of strangulation, shown in the image, belongs to the category of garroting, which involves the use of a ligature tightened by a lever or similar mechanism.</span></p>",
    "correct_choice_id": 52111,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7195,
    "choices": [
      {
        "id": 28748,
        "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Efficacy of drug A is more than that of drug B.</span></span></span></span></span></p>"
      },
      {
        "id": 28749,
        "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">\ufeff\ufeff\ufeffPotency of drug B is more than that of drug A.</span></span></span></span></span></p>"
      },
      {
        "id": 28750,
        "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\">\ufeff\ufeff\ufeff<span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drug A and drug B are agonists</span></span></span><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.</span></span></span></span></span></p>"
      },
      {
        "id": 28751,
        "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">\ufeff\ufeff\ufeffDrug C is a non-competitive antagonist.</span></span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The dose-response curve for three drugs in the same tissue is shown in the image below. Which of the following statements is true?</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/pharmc-1-15.jpg\" style=\"height:201px; width:300px\" /></span></span></span></span></span></p>",
    "unique_key": "Q8775554",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449105,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C.&nbsp;</span></span></strong></span><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drug A and drug B are agonists</span></span></strong></span><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.</span></span></strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">From the given image, it can be understood that the Drug A and Drug B are agonists, i.e., they will bind to the receptor and produce the action after activating it. </span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The drug A is more potent than drug B but the efficacy of both the drugs are the same.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Drug C also produces the action after binding to the receptor, but the degree of the response is less than that of Drugs A and B, or in other words its intrinsic efficacy is not equal to that of drugs A and B. Hence it is a partial agonist. In the presence of full agonists, the partial agonist behaves as an antagonist.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drug C can be a competitive irreversible antagonist (not non-competitive) as the curve is shifting to right and down.</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Statement A: Efficacy of drug A is more than that of drug B:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This statement is false. The efficacy of a drug is determined by the maximum response it can produce. From the graph, both Drug A and Drug B achieve the same maximum response, indicating that their efficacies are the same.</span></span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Statement B: Potency of drug B is more than that of drug A:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This statement is false. Potency is determined by the position of the dose-response curve along the concentration axis. The lower the ED50 (the concentration required to achieve 50% of the maximum response), the more potent the drug. From the graph, Drug A reaches its ED50 at a lower concentration than Drug B, indicating that Drug A is more potent than Drug B.</span></span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Statement D: Drug C is a non-competitive antagonist:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This statement is false. Drug C achieves only a partial response compared to Drugs A and B, indicating that Drug C is a partial agonist, not a non-competitive antagonist. Non-competitive antagonists would typically reduce the efficacy of an agonist without affecting the potency in such a dose-response curve. The curve for Drug C does not align with the expected behavior of a non-competitive antagonist.</span></span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Key Points: </span></span></strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Agonists:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Drugs A and B are full agonists because they can achieve the maximum response.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Partial Agonist:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Drug C produces a submaximal response compared to Drugs A and B, which indicates it is a partial agonist.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Potency:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Drug A is more potent than Drug B because it achieves 50% of its maximum response at a lower concentration.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Non-competitive Antagonist:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Drug C is not a non-competitive antagonist, as it does not simply reduce the efficacy of another agonist but instead acts as a partial agonist on its own.</span></span></span></li>\r\n</ol>",
    "correct_choice_id": 28750,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74571,
    "choices": [
      {
        "id": 297201,
        "text": "<p><span style=\"font-size:16px;\">T3N2M0</span></p>"
      },
      {
        "id": 297202,
        "text": "<p><span style=\"font-size:16px;\">T4bN1M0</span></p>"
      },
      {
        "id": 297203,
        "text": "<p><span style=\"font-size:16px;\">T4aN2M0</span></p>"
      },
      {
        "id": 297204,
        "text": "<p><span style=\"font-size:16px;\">T2N2M1</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Breast cancer of size 6 x 8 cm with dimpling with invasion of Pectoralis Major and ipsilateral matted axillary nodes belongs to what TNM stage? (INICET NOV 2024)</span></p>",
    "unique_key": "Q7068872",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449395,
    "difficulty_level": "beginner",
    "subjects_id": [
      12
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans.&nbsp;A) T3N2M0</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Tumor size &gt; 5 cm = <strong>T3</strong></span></li><li><span style=\"font-size:16px;\">Skin dimpling does not affect T stage (common misconception)</span></li><li><span style=\"font-size:16px;\">Invasion of pectoralis major does not affect T stage</span></li><li><span style=\"font-size:16px;\">Only skin ulceration, peau d'orange, or satellite nodules make it T4b</span></li><li><span style=\"font-size:16px;\">Ipsilateral matted axillary nodes =<strong> N2</strong></span></li><li><span style=\"font-size:16px;\">No mention of distant metastasis = <strong>M0</strong></span></li></ul><p><br><span style=\"font-size:16px;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. T4bN1M0:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Skin dimpling alone does not make it T4b</span></li><li><span style=\"font-size:16px;\">N1 represents mobile nodes, while the question mentions matted nodes (N2)</span><br>&nbsp;</li></ul><p><span style=\"font-size:16px;\"><strong>Option C. T4aN2M0:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">T4a represents chest wall invasion (not including pectoralis major)</span></li><li><span style=\"font-size:16px;\">Invasion of pectoralis major alone does not make it T4a</span><br>&nbsp;</li></ul><p><span style=\"font-size:16px;\"><strong>Option D. T2N2M1:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">T2 is for tumors 2-5 cm, this tumor is &gt; 5 cm</span></li><li><p><span style=\"font-size:16px;\">No evidence of distant metastasis (M1)</span></p><p>&nbsp;</p></li></ul><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Skin dimpling and pectoralis major invasion do not affect T stage in breast cancer TNM staging</span></li><li><span style=\"font-size:16px;\">T3 stage is for tumors &gt; 5 cm</span></li><li><span style=\"font-size:16px;\">Matted axillary nodes represent N2 disease</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-06-05%20141850.jpg\" width=\"984\" height=\"725\"></p>",
    "correct_choice_id": 297201,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13116,
    "choices": [
      {
        "id": 52426,
        "text": "<p><span style=\"font-size:12.0pt;\">Retinoblastoma</span></p>"
      },
      {
        "id": 52427,
        "text": "<p><span style=\"font-size:12.0pt;\">Cavernous Hemangioma</span></p>"
      },
      {
        "id": 52428,
        "text": "<p><span style=\"font-size:12.0pt;\">Orbital Cellulitis</span></p>"
      },
      {
        "id": 52429,
        "text": "<p><span style=\"font-size:12.0pt;\">Rhabdomyosarcoma</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 5-year-old boy was brought with the complaints of protrusion of the right eye with no h/o fever. CT Scan showed a well-defined mass in the orbit with an irregular border and adjacent bony destruction. Biopsy showed small, round cells which were positive for Desmin in Immunohistochemistry. What is the probable diagnosis? (</span>AIIMS Nov 2018)</p>",
    "unique_key": "Q7754771",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449074,
    "difficulty_level": "intermediate",
    "subjects_id": [
      8
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D) Rhabdomyosarcoma&nbsp;</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Rhabdomyosarcoma is the most likely diagnosis based on the clinical and histological findings. It is a malignant tumor derived from skeletal muscle and commonly presents in the pediatric population as a rapidly enlarging orbital mass, often causing displacement of the eye (proptosis). The biopsy findings of small, round cells positive for Desmin, a muscle-specific intermediate filament, support the diagnosis. The location and aggressive nature of the tumor, indicated by bony destruction, are characteristic of rhabdomyosarcoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Retinoblastoma:</strong> This is a common malignant intraocular tumor of childhood but would not typically present with bony destruction or be positive for Desmin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Cavernous Hemangioma:</strong> This is a benign vascular tumor seen in adults and is not associated with rapid progression or positive Desmin staining.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Orbital Cellulitis:</strong> This infection would present with signs of inflammation and fever, which are not described in the scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/05/screenshot-2024-07-05-112128.png\" alt=\"\" width=\"1000\" height=\"470\"></p>",
    "correct_choice_id": 52429,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7052,
    "choices": [
      {
        "id": 28176,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increase the dose</span></span></span></p>"
      },
      {
        "id": 28177,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decrease the dose</span></span></span></p>"
      },
      {
        "id": 28178,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Stop the drug</span></span></span></p>"
      },
      {
        "id": 28179,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Stop retigabine and start on carbamazepine</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient who was diagnosed with epilepsy was put on retigabine thrice a day. Now phenytoin is being added. Which of the following changes should be made to retigabine therapy?</span></span></p>",
    "unique_key": "Q8416392",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449306,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Increase the dose</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In the scenario where phenytoin is added to a patient&#39;s epilepsy treatment regimen that already includes retigabine, and if one of the provided options must be chosen, the most appropriate choice, based on known pharmacological interactions, would be:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The rationale for this choice is based on the enzyme-inducing properties of phenytoin. Phenytoin is known to induce hepatic enzymes that metabolize many drugs, potentially leading to reduced levels of these drugs. The general principle of enzyme induction suggests that the levels of retigabine could be decreased when phenytoin is added. Therefore, an increase in the dose of retigabine may be necessary to maintain therapeutic drug levels and effective seizure control.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">However, it&#39;s important to emphasize that any dose adjustment should be made cautiously and based on clinical monitoring, including assessing the efficacy of seizure control and watching for any potential side effects. The decision should be individualized and ideally supported by drug level monitoring if available.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Decrease the dose</strong>: Decreasing the dose of retigabine would be counterproductive, as the enzyme-inducing effect of phenytoin would lower the drug levels, requiring an increase rather than a decrease.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Stop the drug</strong>: Stopping retigabine is not advisable without a clear indication of severe side effects or failure to control seizures. Retigabine can be an effective antiepileptic, and its discontinuation should be based on clinical judgment and not just due to the addition of another drug.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D</span></strong><span style=\"font-size:12.0pt\">.&nbsp;<strong>Stop retigabine and start on carbamazepine</strong>: This option suggests switching to another antiepileptic drug. While carbamazepine is another enzyme inducer like phenytoin, switching medications is not necessary unless there are specific reasons to do so, such as intolerability or ineffectiveness of retigabine.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">When phenytoin, an enzyme inducer, is added to a regimen that includes retigabine, the dose of retigabine should be increased to compensate for the increased metabolism and maintain effective seizure control.</span></span></span></p>",
    "correct_choice_id": 28176,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 9773,
    "choices": [
      {
        "id": 39059,
        "text": "<p><span style=\"font-size:12.0pt;\">Vimentin</span></p>"
      },
      {
        "id": 39060,
        "text": "<p><span style=\"font-size:12.0pt;\">Tubulin</span></p>"
      },
      {
        "id": 39061,
        "text": "<p><span style=\"font-size:12.0pt;\">Desmin</span></p>"
      },
      {
        "id": 39062,
        "text": "<p><span style=\"font-size:12.0pt;\">Neurofilament</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not an intermediate filament?</span> (AIIMS MAY 2019)</p>",
    "unique_key": "Q9011249",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449080,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Tubulin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Tubulin is a part of microtubules and is not an intermediate filament</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The intermediate filaments comprise the major component of the cytoskeleton and consist of five major subgroups\u2014vimentin, keratins, desmin, neurofilaments, and glial fibrillary acidic protein (GFAP)\u2014and a small number of minor subgroups (e.g., nestin, peripherin).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/02/screenshot-2024-09-02-114628.png\" alt=\"\" width=\"1000\" height=\"457\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Vimentin</strong>: Vimentin is an intermediate filament protein commonly found in cells of mesenchymal origin. It helps maintain cellular integrity and provides resistance to stress.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Desmin</strong>: Desmin is an intermediate filament protein found predominantly in muscle cells. It is crucial for maintaining the structural integrity of muscle cells by linking the cytoskeletal network to the sarcomere.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Neurofilament</strong>: Neurofilaments are intermediate filaments found in neurons. They are important for maintaining the shape and strength of nerve cells and play a role in the conduction of nerve impulses.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tubulin is not an intermediate filament; it is a protein that forms microtubules, which are essential for cell shape, motility, and division. Intermediate filaments, such as vimentin, desmin, and neurofilaments, provide mechanical support and structural integrity to cells.</span></p>",
    "correct_choice_id": 39060,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11605,
    "choices": [
      {
        "id": 46386,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4</span></p>"
      },
      {
        "id": 46387,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 3</span></p>"
      },
      {
        "id": 46388,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2</span></p>"
      },
      {
        "id": 46389,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Chronic HBV infection would be consistent with which of the following serology? </span><span style=\"font-size:11pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">HBsAg</span></li><li><span style=\"font-size:12.0pt;\">Anti-HBsAg</span></li><li><span style=\"font-size:12.0pt;\">Anti-HBcAg</span></li><li><span style=\"font-size:12.0pt;\">HBV DNA</span></li></ol>",
    "unique_key": "Q4311905",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449300,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>A) 1, 3, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Anti-HBs (Hepatitis B surface antibody)</strong>: This antibody appears after the infection has been cleared or following successful vaccination. It indicates immunity to HBV. In chronic HBV infection, this antibody is not present since the surface antigen is still active.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chronic hepatitis B virus (HBV) infection is defined by the persistence of the surface antigen (HBsAg) for more than six months. The presence of HBsAg indicates an active HBV infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Serological markers:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. HBsAg (Hepatitis B surface antigen)</strong>: This antigen indicates that the person is infectious. It is found in the blood during acute and chronic HBV infection. The presence of HBsAg for more than six months defines chronic HBV infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Anti-HBc (Hepatitis B core antibody)</strong>: This antibody indicates previous or ongoing infection with HBV. In chronic infection, the IgG fraction of anti-HBc is usually present.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. HBV DNA</strong>: The presence of HBV DNA in the blood indicates active viral replication. It is usually detectable in chronic HBV infection, although the levels can vary.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chronic HBV infection is characterized by the persistence of HBsAg, the presence of Anti-HBc, and usually detectable HBV DNA. Anti-HBs is not present in chronic HBV infection as it indicates immunity.</span></p>",
    "correct_choice_id": 46386,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "INICET",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 59994,
    "choices": [
      {
        "id": 239277,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-D, 2-B, 3-A, 4-C</span></span></p>"
      },
      {
        "id": 239278,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-C, 2-B, 3-D, 4-A</span></span></p>"
      },
      {
        "id": 239279,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-C, 2-D, 3-B, 4-A</span></span></p>"
      },
      {
        "id": 239280,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-D, 2-C, 3-B, 4-A</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following: (INICET NOV 2022)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1 - Kleptomania<br />\r\n2 - Pyromania<br />\r\n3 - Mutilomania<br />\r\n4 - Dipsomania</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A - Intense desire to drink alcoholic drinks<br />\r\nB - Intense desire to mutilate<br />\r\nC - Intense desire to steal items of trivial value<br />\r\nD - Intense desire to burn things</span></span></span></p>",
    "unique_key": "Q8395555",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449067,
    "difficulty_level": "intermediate",
    "subjects_id": [
      16
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) 1-C, 2-D, 3-B, 4-A</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The correct option is <strong>1-C, 2-D, 3-B, 4-A</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Impulse control disorders are characterized by the <strong>repeated failure to resist an impulse, drive, or urge</strong> to perform an act that is rewarding to the person, at least in the short term, despite the long-term harm either to the individual or to others. These disorders involve marked distress about the behavior pattern or impairment in personal, family, social, educational, or other important areas of functioning.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These disorders include:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyromania</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The deliberate setting of fires on more than one occasion.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kleptomania</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The recurrent inability to resist urges to steal objects that are of little or no personal use.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Compulsive sexual behavior disorder</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (not directly in this question but part of impulse control disorders).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intermittent explosive disorder</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Repeated episodes of impulsive, aggressive, violent behavior.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kleptomania</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is the repeated failure to resist impulses to steal objects of trivial value, and the act is not driven by personal need. The stolen items are typically returned, given away, or kept hidden.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyromania</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> involves the intentional setting of fires, and is associated with disorders like <strong>substance abuse</strong>, <strong>depression</strong>, and <strong>personality disturbances</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dipsomania</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> refers to an irresistible impulse to consume alcoholic beverages at periodic intervals.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mutilomania</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is the irresistible urge to mutilate animals.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Impulse control disorders include <strong>kleptomania</strong> (urge to steal), <strong>pyromania</strong> (urge to set fires), <strong>dipsomania</strong> (urge to drink alcohol), and <strong>mutilomania</strong> (urge to mutilate). These behaviors are driven by compulsions and often result in distress or impairment despite their immediate rewarding nature.</span></span></span></p>",
    "correct_choice_id": 239279,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 10078,
    "choices": [
      {
        "id": 40278,
        "text": "<p><span style=\"font-size:12.0pt;\">1-c, 2-b, 3-d, 4-a</span></p>"
      },
      {
        "id": 40279,
        "text": "<p><span style=\"font-size:12.0pt;\">1-b, 2-c, 3-d, 4-a</span></p>"
      },
      {
        "id": 40280,
        "text": "<p><span style=\"font-size:12.0pt;\">1-d, 2-c, 3-b, 4-a</span></p>"
      },
      {
        "id": 40281,
        "text": "<p><span style=\"font-size:12.0pt;\">1-b, 2-d, 3-c, 4-a</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Match the malignancies with the responsible genes:</span> <span style=\"font-size:12.0pt;\">(INICET MAY 2022)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-131400.jpg\" alt=\"\" width=\"700\" height=\"307\"></p><p>&nbsp;</p>",
    "unique_key": "Q6954845",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449069,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 1-d, 2-c, 3-b, 4-a</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/03/screenshot-2024-09-03-130635.png\" alt=\"\" width=\"1000\" height=\"328\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Pleomorphic adenoma</strong>: This benign salivary gland tumor is associated with the overexpression of the <strong>Plag-1</strong> proto-oncogene. Plag-1 plays a significant role in the tumorigenesis of pleomorphic adenoma, making option <strong>d</strong> the correct match.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Burkitt's lymphoma</strong>: This aggressive B-cell non-Hodgkin lymphoma is most commonly associated with the translocation of the <strong>C-myc</strong> gene, particularly t(8;14) or t(8;22). This translocation leads to the overexpression of the C-myc oncogene, driving the proliferation of lymphoid cells, making option <strong>c</strong> the correct match.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Neuroblastoma</strong>: Neuroblastoma is the most common extracranial solid tumor in childhood and is associated with amplification of the <strong>N-myc</strong> gene. N-myc plays a critical role in the aggressive behavior of neuroblastoma, making option <strong>b</strong> the correct match.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Retinoblastoma</strong>: Retinoblastoma, the most common primary intraocular malignancy in children, is associated with mutations in the <strong>Rb</strong> gene. The Rb gene is a tumor suppressor that regulates cell cycle progression, and its inactivation leads to uncontrolled cell division, making option <strong>a</strong> the correct match.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-131818.jpg\" alt=\"\" width=\"1000\" height=\"293\"></p>",
    "correct_choice_id": 40280,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73645,
    "choices": [
      {
        "id": 293521,
        "text": "<p><span style=\"font-size:12.0pt;\">A-4, B-3, C-1, D-2</span></p>"
      },
      {
        "id": 293522,
        "text": "<p><span style=\"font-size:12.0pt;\">A-3, B-2, C-4, D-1</span></p>"
      },
      {
        "id": 293523,
        "text": "<p><span style=\"font-size:12.0pt;\">A-2, B-1, C-3, D-4</span></p>"
      },
      {
        "id": 293524,
        "text": "<p><span style=\"font-size:12.0pt;\">A-3, B-2, C-1, D-4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Match the following pathological bodies with their associated condition: (INICET NOV 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_vckL9VL.png\" width=\"954\" height=\"249\"></span></p>",
    "unique_key": "Q7672949",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449289,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) A-3, B-2, C-1, D-4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The correct pairing of pathological bodies with their associated conditions is:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Parkinson's Disease</strong> - Lewy body (A-3): Lewy bodies are intracellular inclusions found in neurons of substantia nigra in Parkinson's disease</span></li><li><span style=\"font-size:16px;\"><strong>Rabies&nbsp;</strong>- Negri body (B-2): Negri bodies are pathognomonic intracytoplasmic inclusions found in neurons infected with rabies virus</span></li><li><span style=\"font-size:16px;\"><strong>Multiple myeloma</strong> - Dutcher body (C-1): Dutcher bodies are intranuclear inclusions found in plasma cells in multiple myeloma</span></li><li><span style=\"font-size:16px;\"><strong>Malakoplakia</strong> - Michaelis-Gutmann body (D-4): These are pathognomonic intracellular calcified bodies found in macrophages in malakoplakia</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Lewy bodies \u2192 Parkinson's disease</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_7wXpMOe.png\" width=\"547\" height=\"289\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Negri bodies \u2192 Rabies</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_u1lzjMj.png\" width=\"603\" height=\"391\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Dutcher bodies \u2192 Multiple myeloma</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-06-05%20114104.jpg\" width=\"734\" height=\"504\"></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Michaelis-Gutmann bodies \u2192 Malakoplakia</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_mf4o5qa.png\" width=\"517\" height=\"353\"></span></p>",
    "correct_choice_id": 293524,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 24396,
    "choices": [
      {
        "id": 97545,
        "text": "<p><span style=\"font-size:12.0pt;\">Suicidal tendency</span></p>"
      },
      {
        "id": 97546,
        "text": "<p><span style=\"font-size:12.0pt;\">Agranulocytosis</span></p>"
      },
      {
        "id": 97547,
        "text": "<p><span style=\"font-size:12.0pt;\">Myocarditis</span></p>"
      },
      {
        "id": 97548,
        "text": "<p><span style=\"font-size:12.0pt;\">Cerebral bleeding</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">What is an infrequent yet highly serious adverse outcome of clozapine that necessitates consistent monitoring?</span></p>",
    "unique_key": "Q6009427",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449092,
    "difficulty_level": "beginner",
    "subjects_id": [
      16
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Agranulocytosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>CLOZAPINE</u></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Treatment-resistant schizophrenia (TRS)- </strong>Lack of response to at least two different antipsychotics, including at least one second-generation antipsychotic, given in adequate dosage and for an adequate duration (at least 4-6 weeks).</span></li><li><span style=\"font-size:12.0pt;\">Clozapine is the drug of choice (DOC) in TRS.</span></li><li><span style=\"font-size:12.0pt;\">Unique mechanism of action- More affinity for D4 than D2, hence causes <strong>minimal EPS.</strong></span></li><li><span style=\"font-size:12.0pt;\">Antipsychotic that causes <strong>max weight gain.</strong></span></li><li><span style=\"font-size:12.0pt;\">Clozapine is the only antipsychotic with <strong>antisuicide property.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Side effects of clozapine</u></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Life-threatening: Agranulocytosis (idiosyncratic), myocarditis (idiosyncratic), seizures (dose-dependent)</span></li><li><span style=\"font-size:12.0pt;\">Sedation (most common), sialorrhea</span></li><li><span style=\"font-size:12.0pt;\">Syncope, hypotension, tachycardia, nausea, vomiting</span></li><li><span style=\"font-size:12.0pt;\">Weight gain, anticholinergic side effects</span></li><li><span style=\"font-size:12.0pt;\">Due to the possibility of agranulocytosis, when a patient is on clozapine, <strong>ANC and TLC monitoring </strong>is required.</span></li><li><span style=\"font-size:12.0pt;\">The regime of monitoring-</span><ul><li><span style=\"font-size:12.0pt;\">First 6 months- Once a week</span></li><li><span style=\"font-size:12.0pt;\">Next 6 months- Once in two weeks</span></li><li><span style=\"font-size:12.0pt;\">After 1 year- Once in four weeks, till clozapine is continued</span>&nbsp;</li></ul></li><li><span style=\"font-size:12.0pt;\">Stop clozapine, if WBC &lt; 3000/dl or ANC &lt; 1500/dl</span></li><li><span style=\"font-size:12.0pt;\">Contraindications for clozapine use</span><ul><li><span style=\"font-size:12.0pt;\">WBC &lt; 3500/dl</span></li><li><span style=\"font-size:12.0pt;\">History of agranulocytosis on clozapine</span></li><li><span style=\"font-size:12.0pt;\">Use of other bone marrow suppressants like carbamazepine</span></li></ul></li></ul>",
    "correct_choice_id": 97546,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7034,
    "choices": [
      {
        "id": 28104,
        "text": "<p><span style=\"font-size:12pt;\">Protects the acid labile drug from gastric acidity</span></p>"
      },
      {
        "id": 28105,
        "text": "<p><span style=\"font-size:12pt;\">Protects the gastric mucosa from irritant effects of certain drugs</span></p>"
      },
      {
        "id": 28106,
        "text": "<p><span style=\"font-size:12pt;\">Prolongs the half-life of the drug</span></p>"
      },
      {
        "id": 28107,
        "text": "<p><span style=\"font-size:12pt;\">Delivers drugs distal to stomach</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Many drugs are given as enteric coated tablets. All of the following are the advantages of enteric coating of drugs EXCEPT? (AIIMS MAY 2020)</span><br>&nbsp;</p>",
    "unique_key": "Q6458337",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449090,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Prolongs the half-life of the drug</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Enteric coatings on tablets protect acid-labile drugs from gastric acidity, protect the gastric mucosa from irritant effects, and deliver drugs distal to the stomach. However, they do not prolong the half-life of a drug, which is determined by the drug's metabolism and elimination from the body.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Enteric-coated drugs are designed with a special coating that resists dissolution in the acidic environment of the stomach. This coating dissolves instead in the more alkaline environment of the small intestine. The primary purposes of this enteric coating are:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Protect the acid-labile drug from gastric acidity:&nbsp;</strong>Some drugs are unstable in the acidic environment of the stomach and can be degraded before they have a chance to be absorbed. Enteric coating protects these drugs from the acidic gastric environment, ensuring they reach the intestine, where they can be absorbed effectively.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Protect the gastric mucosa from the irritant effects of certain drugs:&nbsp;</strong>Certain drugs can irritate the gastric mucosa, leading to discomfort or even ulcers. Enteric coating prevents these drugs from being released in the stomach, thereby reducing the risk of gastric irritation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Deliver drugs distal to the stomach:&nbsp;</strong>Enteric coating is also used to ensure that a drug is released in the intestine rather than the stomach, which can be important for drugs that are intended to act in the intestine or are better absorbed from the intestinal lining.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Enteric coating is primarily used to protect acid-labile drugs from gastric acidity, protect the gastric mucosa from irritant effects, and ensure drug delivery distal to the stomach. It does not prolong the half-life of the drug.</span></p>",
    "correct_choice_id": 28106,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 24698,
    "choices": [
      {
        "id": 98753,
        "text": "<p><span style=\"font-size:12.0pt;\">Ripstein operation</span></p>"
      },
      {
        "id": 98754,
        "text": "<p><span style=\"font-size:12.0pt;\">Thiersch operation</span></p>"
      },
      {
        "id": 98755,
        "text": "<p><span style=\"font-size:12.0pt;\">Altemeier procedure</span></p>"
      },
      {
        "id": 98756,
        "text": "<p><span style=\"font-size:12.0pt;\">Delorme operation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following procedures is not performed via the perineal approach in a patient with rectal prolapse? </span><span style=\"font-size:11.0pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2023)</span></p>",
    "unique_key": "Q9428491",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449293,
    "difficulty_level": "beginner",
    "subjects_id": [
      12
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Ripstein operation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This procedure is designed to treat rectal prolapse. It involves fixing the rectum to the sacrum using a synthetic mesh. This procedure is performed via an abdominal approach and not through the perineum. Hence, the answer to the question is A) Ripstein operation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Thiersch operation:&nbsp;</strong>The Thiersch operation is a perineal procedure. It involves placing a wire or other synthetic material around the anus to encircle and narrow it. This provides support to the anal canal and rectum, helping to prevent or treat rectal prolapse.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Altemeier procedure:&nbsp;</strong>Also known as the perineal rectal resection, the Altemeier procedure is a surgical treatment for rectal prolapse. During this operation, the prolapsed portion of the rectum is resected, and the remaining rectum is sutured back to the anal canal. This procedure is performed through the perineal approach.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Delorme operation:&nbsp;</strong>The Delorme operation is a perineal approach to treat rectal prolapse. The mucosa and submucosa of the prolapsed rectum are excised, and the muscularis is plicated. The remaining mucosa is then sutured back. This procedure is typically reserved for older patients or those who are not candidates for a more invasive abdominal procedure.</span></p>",
    "correct_choice_id": 98753,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 54301,
    "choices": [
      {
        "id": 216673,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acyclovir</span></span></span></p>"
      },
      {
        "id": 216674,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Corticosteroids</span></span></span></p>"
      },
      {
        "id": 216675,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Antibiotics</span></span></span></p>"
      },
      {
        "id": 216676,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Physiotherapy</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 40-year-old patient presented with left facial weakness. Routine lab workup was normal. What is the next best step in management?</span></span></span>&nbsp;(INICET MAY 2024)</p>",
    "unique_key": "Q6451864",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449307,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Corticosteroids</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The presentation of left facial weakness with normal routine lab workup suggests Bell&#39;s palsy, an idiopathic condition characterized by sudden onset of unilateral lower motor neuron facial paralysis. Bell&#39;s palsy is a diagnosis of exclusion and is the most common cause of unilateral facial paralysis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Corticosteroids:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> The first-line treatment for Bell&#39;s palsy is corticosteroids. They are most effective when started within 72 hours of symptom onset. Early treatment with corticosteroids can significantly improve the chances of complete recovery. A typical regimen is prednisolone or prednisone.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dosage:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Prednisone 60-80 mg per day for 5-7 days, followed by a taper over the next 5-7 days.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Note &ndash; In t</span><span style=\"font-size:12.0pt\">he severity grading system, <strong>House-Brackmann grading</strong>, if the patient has <strong>Grade 4 or Grade 5</strong> severity, consider adding <strong>antivirals</strong> such as <strong>acyclovir</strong> or <strong>valacyclovir</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acyclovir:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Although acyclovir or other antiviral agents like valacyclovir are sometimes used, their benefit is less clear. They may be considered in severe cases of Bell&#39;s palsy, particularly when there is a suspicion of herpes simplex virus involvement, but they are not the primary treatment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dosage:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Valacyclovir 1 gram TID for 7 days or acyclovir 400 mg five times a day for 7-10 days.</span> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Note - </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Valacyclovir</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> has superior bioavailability, superior efficacy, and lower side effects compared to <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">acyclovir</span></strong><strong>.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Antibiotics:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> There is no role for antibiotics in the treatment of Bell&#39;s palsy as it is not caused by a bacterial infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Physiotherapy:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> While physiotherapy, including facial exercises and eye protection measures, can be supportive, it is not the primary treatment and should be considered an adjunct to corticosteroid therapy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The best initial management for a patient with Bell&#39;s palsy is corticosteroid therapy. Early administration within 72 hours of symptom onset greatly enhances the likelihood of complete recovery. Antivirals may be added in severe cases, but they are not the mainstay of treatment.</span></span></p>",
    "correct_choice_id": 216674,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 52114,
    "choices": [
      {
        "id": 207957,
        "text": "<p><span style=\"font-size:12.0pt;\">CT uses non-filtered X-rays</span></p>"
      },
      {
        "id": 207958,
        "text": "<p><span style=\"font-size:12.0pt;\">Radiation exposure in CT scan is 20mSv</span></p>"
      },
      {
        "id": 207959,
        "text": "<p><span style=\"font-size:12.0pt;\">CT is the initial investigation for gallstones</span></p>"
      },
      {
        "id": 207960,
        "text": "<p><span style=\"font-size:12.0pt;\">HU of water is zero</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Identify the correct statement: (INICET MAY 2024)</span></p>",
    "unique_key": "Q2111859",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449304,
    "difficulty_level": "beginner",
    "subjects_id": [
      17
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) HU of water is zero</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Hounsfield Unit (HU) is a measure of radiodensity used in computed tomography (CT) scanning. By definition, the HU of water is zero, and this value serves as the reference point for measuring the density of other tissues. Values greater than zero indicate substances denser than water (e.g., bone, contrast material), while values less than zero indicate less dense substances (e.g., fat, air).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. CT uses non-filtered X-rays:</strong> This statement is incorrect. CT scans use filtered X-rays to remove low-energy X-rays that would not contribute to image formation but would increase patient radiation exposure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Radiation exposure in CT scan is 20mSv:</strong> This is incorrect. Typical radiation doses for CT scans vary based on the body part being imaged. A head CT scan, for instance, typically involves a radiation dose of around 2 mSv, while an abdominal CT scan might be around 5 mSv. A dose of 20 mSv would be exceedingly high for a single CT scan.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. CT is the initial investigation for gallstones:</strong> This is incorrect. Ultrasound is the initial investigation of choice for gallstones due to its high sensitivity, specificity, and lack of ionizing radiation. CT is more commonly used for other types of stones, such as kidney stones.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Hounsfield Unit (HU) of water is zero, serving as a reference point for measuring the radiodensity of various tissues in CT imaging.</span></p>",
    "correct_choice_id": 207960,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6908,
    "choices": [
      {
        "id": 27600,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Thyroxine</span></p>"
      },
      {
        "id": 27601,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Epinephrine</span></p>"
      },
      {
        "id": 27602,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Glucagon</span></p>"
      },
      {
        "id": 27603,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Parathormone</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of these hormones have intracellular receptors? (</span>INICET Nov 2020)</p>",
    "unique_key": "Q6905634",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449104,
    "difficulty_level": "beginner",
    "subjects_id": [
      2
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Thyroxine</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Thyroxine hormone act by binding to intracellular nuclear receptors.</span></li><li><span style=\"font-size:12.0pt;\">All other hormones mentioned in the options bind to receptors on the cell membrane.</span></li><li><span style=\"font-size:12.0pt;\">Thyroxine crosses the plasma membrane for its action.</span></li><li><span style=\"font-size:12.0pt;\">The thyroid hormone receptors are either attached to the DNA genetic strands or located in proximity to them. The thyroid hormone receptor usually forms a heterodimer with retinoid X receptor (RXR) at specific thyroid hormone response elements on the DNA. On binding with thyroid hormone, the receptors become activated and initiate the transcription process.</span></li><li><span style=\"font-size:12.0pt;\">Then large numbers of different types of messenger RNA are formed, followed within another few minutes or hours by RNA translation on the cytoplasmic ribosomes to form hundreds of new intracellular proteins.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Epinephrine</strong>: Epinephrine binds to adrenergic receptors on the cell membrane, which are G protein-coupled receptors, and does not use intracellular receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Glucagon</strong>: Glucagon binds to glucagon receptors on the cell membrane, which are also G protein-coupled receptors, and does not use intracellular receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Parathormone</strong>: Parathormone (PTH) binds to PTH receptors on the cell membrane, which are G protein-coupled receptors, and does not use intracellular receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thyroxine acts by binding to intracellular nuclear receptors, initiating transcription and subsequent protein synthesis. This distinguishes it from hormones like epinephrine, glucagon, and parathormone, which bind to receptors on the cell membrane.</span></p>",
    "correct_choice_id": 27600,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74700,
    "choices": [
      {
        "id": 297713,
        "text": "<p><span style=\"font-size:16px;\">Fasting Hypoglycemia and Postprandial Hyperglycemia</span></p>"
      },
      {
        "id": 297714,
        "text": "<p><span style=\"font-size:16px;\">Increase SBP and DBP at 6 weeks</span></p>"
      },
      {
        "id": 297715,
        "text": "<p><span style=\"font-size:16px;\">Increase in RBC mass</span></p>"
      },
      {
        "id": 297716,
        "text": "<p><span style=\"font-size:16px;\">Peripheral Insulin Resistance</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Physiological changes in pregnancy include all of the following except: (INICET NOV 2024)</span></p>",
    "unique_key": "Q9125782",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449393,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Increase in SBP and DBP at 6 weeks</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">During pregnancy, blood pressure decreases throughout pregnancy, with the maximum fall occurring in the second trimester. This is a normal physiological adaptation. An increase in blood pressure (<strong>either systolic or diastolic</strong>) is <strong>not a normal physiological change and could indicate a pathological condition like preeclampsia.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Fasting Hypoglycemia and Postprandial Hyperglycemia:&nbsp;</strong>This is incorrect as this is a normal physiological change in pregnancy. Pregnant women experience fasting hypoglycemia and postprandial hyperglycemia as part of normal pregnancy adaptation.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Increase in RBC mass:&nbsp;</strong>This is incorrect as this is a normal physiological change. During pregnancy, there is an increase in RBC mass, although the increase in plasma volume is proportionally greater, leading to physiological anemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Peripheral Insulin Resistance</strong>: This is incorrect as this is a normal physiological change. Pregnancy is characterized by increased peripheral insulin resistance, which puts women at higher risk of developing gestational diabetes mellitus.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p><br><span style=\"font-size:16px;\">Blood pressure normally <strong>decreases during pregnancy</strong>, with maximum fall in the second trimester. Any increase in blood pressure during pregnancy is abnormal and requires evaluation.</span></p>",
    "correct_choice_id": 297714,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13123,
    "choices": [
      {
        "id": 52454,
        "text": "<p><span style=\"font-size:12.0pt;\">POAG</span></p>"
      },
      {
        "id": 52455,
        "text": "<p><span style=\"font-size:12.0pt;\">Hypoplasia of optic disc</span></p>"
      },
      {
        "id": 52456,
        "text": "<p><span style=\"font-size:12.0pt;\">Papilledema</span></p>"
      },
      {
        "id": 52457,
        "text": "<p><span style=\"font-size:12.0pt;\">Medullated nerve fibres</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">All are causes for expanding blind spot, except? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">AIIMS Nov 2019)</span></p>",
    "unique_key": "Q6068951",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449095,
    "difficulty_level": "intermediate",
    "subjects_id": [
      8
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Hypoplasia of optic disc</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Expansion of blind spot is not seen in optic disc hypoplasia. Optic nerve hypoplasia is the most common congenital optic disc anomaly that presents due to the underdevelopment of the optic nerve. The optic disc is surrounded by a yellowish pigmented ring known as a <strong>\"double-ring\" sign. </strong>This condition does not typically lead to changes in the size of the blind spot, as it primarily affects the development of the optic nerve rather than its function related to the blind spot's expansion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/asdcadas.jpg\" alt=\"\" width=\"400\" height=\"378\"></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Physiological blind spot is an area of absolute scotoma caused by the absence of photoreceptors in the region occupied by the optic disc.</span></li><li><span style=\"font-size:12.0pt;\">Lesions affecting the optic disc region can expand the blind spot.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. POAG:</strong></span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">The rise in IOP in primary open-angle glaucoma causes pressure on the optic nerve head and consequent atrophy leading to expansion of the blindspot.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Papilledema:</strong></span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">Papilledema is a passive disc swelling associated with raised intracranial pressure, and the edematous optic disc is swollen beyond its usual margins, causing the blind spot to enlarge.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Medullated nerve fibres:</strong></span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">Medullated nerve fibers (optic disc medullation) is a condition of abnormal myelination of the nerve fibers of the retina, where myelination continues beyond lamina cribrosa and spreads into the retina beyond the optic disc. This leads to the expansion of the blind spot.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Optic disc hypoplasia, a congenital underdevelopment of the optic nerve, does not typically result in an expanding blind spot, unlike conditions like POAG, papilledema, and the presence of medullated nerve fibers, which can directly affect the structure or function of the area surrounding the optic disc.</span></p>",
    "correct_choice_id": 52455,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14059,
    "choices": [
      {
        "id": 56197,
        "text": "<p><span style=\"font-size:12.0pt;\">Eyes-2, Verbal-1, Motor-5</span></p>"
      },
      {
        "id": 56198,
        "text": "<p><span style=\"font-size:12.0pt;\">Eyes-2, Verbal-NT, Motor-5</span></p>"
      },
      {
        "id": 56199,
        "text": "<p><span style=\"font-size:12.0pt;\">Eyes-3, Verbal-1, Motor-6</span></p>"
      },
      {
        "id": 56200,
        "text": "<p><span style=\"font-size:12.0pt;\">Eyes-3, Verbal-NT, Motor-6</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient was admitted after a road traffic accident and later put on mechanical ventilation. He opens his eyes to verbal command and moves all four limbs spontaneously. Calculate his GCS: (AIIMS NOV 2018)</span></p>",
    "unique_key": "Q7528488",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449294,
    "difficulty_level": "beginner",
    "subjects_id": [
      12
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Eyes-3, Verbal-NT, Motor-6</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">His GCS is Eyes-3, Verbal-NT, Motor-6.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Eye-opening to verbal command \u2013 3</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Movement of all 4 limbs spontaneously \u2013 6</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the case of endotracheal intubation, as given here, the verbal response score is noted as NT.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Total GCS score is not recorded since one of the components is non-testable (NT).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/20/glasgow-coma-scale.jpg\" alt=\"\" width=\"1000\" height=\"939\"></p>",
    "correct_choice_id": 56200,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "CriteriaBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 23228,
    "choices": [
      {
        "id": 92876,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Weight loss+ Metformin + induction of ovulation with urinary gonadotrophins</span></span></span></p>"
      },
      {
        "id": 92877,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Weight loss + folic acid, Try for spontaneous induction, if failed move to induction of ovulation</span></span></span></p>"
      },
      {
        "id": 92878,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metformin + finasteride + Induction of ovulation</span></span></span></p>"
      },
      {
        "id": 92879,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Weight loss+ Metformin + Induction of ovulation with clomiphene</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 23-year-old woman, experiencing 6 years of infertility, possesses a BMI of 33 and exhibits facial hair. Further investigations have diagnosed her with polycystic ovary syndrome (PCOS) and observed tubal spillage from both sides. Given her desire to conceive with her husband, what would be the most suitable management plan for her?&nbsp;</span></span></span>(INICET MAY 2023)</p>",
    "unique_key": "Q9086830",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449076,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Weight loss + folic acid, try for spontaneous induction, if failed move to induction of ovulation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Notably, even a modest weight loss (approximately 5% of body weight) can be beneficial for restoring ovulatory cycles in some obese PCOS patients. Therefore, spontaneous induction is attempted as the first option. Additionally, folic acid is routinely administered as a preventive measure before conception to reduce the risk of neural tube defects.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/15/whatsapp-image-2023-06-12-at-190121011010201026_page_47.jpg\" style=\"height:1225px; width:1000px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Weight loss + Metformin + induction of ovulation with urinary gonadotrophins</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While weight loss and Metformin are both appropriate treatments for PCOS, initiating ovulation induction with urinary gonadotrophins might be premature. Typically, less invasive methods such as Clomiphene or Letrozole are tried before using gonadotrophins.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Metformin + finasteride + Induction of ovulation</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This option includes Metformin, which is beneficial for insulin resistance in PCOS, and finasteride, which is used for hirsutism but not typically for fertility management. Finasteride is not used to induce ovulation. This plan overlooks the initial approach of weight loss and the potential for spontaneous ovulation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Weight loss + Metformin + Induction of ovulation with clomiphene</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This option is partially correct. While weight loss and Metformin are appropriate, the recommendation to immediately use Clomiphene for induction without trying for spontaneous ovulation is not aligned with the step-wise approach in fertility management.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For a woman with PCOS and infertility, the initial management should include weight loss and folic acid supplementation, with attempts at spontaneous ovulation before progressing to more invasive induction methods.</span></span></span></p>",
    "correct_choice_id": 92877,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 10359,
    "choices": [
      {
        "id": 41402,
        "text": "<p><span style=\"font-size:12.0pt;\">Autosomal-dominant disorder</span></p>"
      },
      {
        "id": 41403,
        "text": "<p><span style=\"font-size:12.0pt;\">X- linked dominant disorder</span></p>"
      },
      {
        "id": 41404,
        "text": "<p><span style=\"font-size:12.0pt;\">Autosomal-recessive disorder</span></p>"
      },
      {
        "id": 41405,
        "text": "<p><span style=\"font-size:12.0pt;\">X- linked recessive disorder</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which pattern of inheritance does the pedigree chart denote? (AIIMS NOV 2018)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/103.jpg\" alt=\"\" width=\"400\" height=\"294\"></span></p>",
    "unique_key": "Q2311077",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449392,
    "difficulty_level": "intermediate",
    "subjects_id": [
      13
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Autosomal-recessive disorder</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The pedigree chart shown suggests an <strong>autosomal-recessive disorder</strong> based on several key observations:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\"><strong>Horizontal Pattern:</strong> The affected individuals appear in the same generation but are not present in the preceding or subsequent generations. This pattern is characteristic of autosomal-recessive inheritance, where the disorder tends to skip generations unless both parents carry the recessive allele.</span></li><li><span style=\"font-size:12pt;\"><strong>Unaffected Parents:</strong> Both parents of affected individuals are unaffected, suggesting they are carriers of the recessive allele. In autosomal-recessive inheritance, an individual must inherit two copies of the mutated gene (one from each parent) to express the disorder.</span></li><li><span style=\"font-size:12pt;\"><strong>Carrier Frequency:</strong> According to autosomal-recessive inheritance patterns, when both parents are carriers, there is a 25% chance that their offspring will have the disorder (inherit two mutated genes), a 50% chance that the offspring will be carriers (inherit one mutated gene and one normal gene), and a 25% chance that the offspring will have a normal genotype (inherit two normal genes).</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Autosomal-dominant disorder:</strong> This pattern typically shows affected individuals in every generation, with both males and females equally likely to inherit the disorder. Affected individuals have a 50% chance of passing the disorder to their offspring, regardless of the other parent's genotype.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. X-linked dominant disorder:</strong> This pattern would show affected females more frequently if the father is affected and can appear in every generation. However, affected males would pass the condition to all of their daughters and none of their sons.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. X-linked recessive disorder:</strong> This pattern is more common in males, as they only have one X chromosome. Carrier females would pass the disorder to 50% of their sons, and 50% of their daughters would be carriers. However, in this pedigree, both males and females are affected equally, and the pattern does not suggest an X-linked inheritance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Autosomal-recessive disorders are typically characterized by a horizontal pattern of inheritance, where the disorder appears in siblings of the same generation but may skip generations, with unaffected parents often being carriers.</span></p>",
    "correct_choice_id": 41404,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 61970,
    "choices": [
      {
        "id": 247141,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thyroid hormone assay</span></span></p>"
      },
      {
        "id": 247142,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum prolactin</span></span></p>"
      },
      {
        "id": 247143,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulin-like growth factor (IGF-1)</span></span></p>"
      },
      {
        "id": 247144,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum testosterone</span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old man presents to the clinic with complaints of progressive enlargement of his hands and feet. On examination, he has frontal bossing, a large tongue, and spade-shaped hands. His shoe size has also increased over the past few years. Which of the following tests is most appropriate for diagnosing his condition? </span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(AIIMS MAY 2017)</span></span></p>",
    "unique_key": "Q2409613",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449100,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans</span></strong><span style=\"font-size:12.0pt\">. <strong>C) Insulin-like growth factor (IGF-1)</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The patient&rsquo;s presentation, including features such as frontal bossing, macroglossia (large tongue), and spade-shaped hands, strongly suggests acromegaly. Acromegaly results from excessive secretion of growth hormone (GH), typically due to a pituitary adenoma. Insulin-like growth factor 1 (IGF-1) is the most reliable screening test for acromegaly because IGF-1 levels remain elevated throughout the day, unlike GH, which fluctuates. Elevated IGF-1 levels suggest acromegaly. A confirmatory test is the oral glucose tolerance test, where GH fails to suppress in acromegaly.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Thyroid hormone assay</span></strong><span style=\"font-size:12.0pt\">: Thyroid function tests are used to diagnose thyroid disorders such as hypothyroidism or hyperthyroidism. These tests are not used to diagnose acromegaly.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Serum prolactin</span></strong><span style=\"font-size:12.0pt\">: Although prolactinomas (prolactin-secreting tumors) are common pituitary adenomas, this patient&#39;s symptoms are not consistent with hyperprolactinemia. Prolactin measurement would not confirm acromegaly.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Serum testosterone</span></strong><span style=\"font-size:12.0pt\">: While testosterone testing may be indicated for evaluating hypogonadism, it is not relevant to the diagnosis of acromegaly.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The most appropriate initial test for diagnosing acromegaly is measuring insulin-like growth factor 1 (IGF-1) levels, as it reflects chronic exposure to elevated growth hormone.</span></span></span></p>",
    "correct_choice_id": 247143,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44024,
    "choices": [
      {
        "id": 175755,
        "text": "<p><span style=\"font-size:12pt;\">RSV</span></p>"
      },
      {
        "id": 175756,
        "text": "<p><span style=\"font-size:12pt;\">Herpes virus</span></p>"
      },
      {
        "id": 175757,
        "text": "<p><span style=\"font-size:12pt;\">EBV</span></p>"
      },
      {
        "id": 175758,
        "text": "<p><span style=\"font-size:12pt;\">CMV</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which virus requires reverse transcriptase PCR for detection? (INICET NOV 2023)</span></p>",
    "unique_key": "Q3508934",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449101,
    "difficulty_level": "intermediate",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) RSV</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Respiratory Syncytial Virus (RSV) is an RNA virus that requires reverse transcription PCR (RT-PCR) to convert its RNA into DNA for detection. RT-PCR is a sensitive method used to detect and quantify RNA viruses by first converting their RNA into complementary DNA (cDNA) using the enzyme reverse transcriptase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Herpes virus: </strong>Herpes viruses are DNA viruses and do not require reverse transcription. They can be detected using standard PCR methods that amplify their DNA directly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. EBV (Epstein-Barr Virus): </strong>Epstein-Barr Virus is a DNA virus and uses standard PCR for detection. Reverse transcription is not necessary for DNA viruses.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. CMV (Cytomegalovirus): </strong>Cytomegalovirus is also a DNA virus and can be detected through standard DNA PCR. Reverse transcription is not needed for its detection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">RSV, an RNA virus, requires reverse transcription PCR (RT-PCR) for detection by converting RNA into DNA.</span></p>",
    "correct_choice_id": 175755,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11731,
    "choices": [
      {
        "id": 46890,
        "text": "<p><span style=\"font-size:12.0pt;\">Cardiac tamponade</span></p>"
      },
      {
        "id": 46891,
        "text": "<p><span style=\"font-size:12.0pt;\">Restrictive cardiomyopathy</span></p>"
      },
      {
        "id": 46892,
        "text": "<p><span style=\"font-size:12.0pt;\">Constrictive pericarditis</span></p>"
      },
      {
        "id": 46893,
        "text": "<p><span style=\"font-size:12.0pt;\">Tricuspid regurgitation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Deep y descent in Jugular Venous Pressure (JVP) is seen in all of the following conditions except: (AIIMS NOV 2019)</span></p>",
    "unique_key": "Q6159479",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449106,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Cardiac Tamponade</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Deep y descent in JVP (Jugular venous pressure) is a characteristic finding in several conditions that affect the filling of the right ventricle. These conditions include constrictive pericarditis, restrictive cardiomyopathy, and tricuspid regurgitation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cardiac tamponade, as it is associated with a blunted y descent in JVP rather than a deep y descent. In cardiac tamponade, the pericardial fluid accumulation restricts cardiac filling, leading to a decrease in the amplitude of the y descent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Restrictive cardiomyopathy:&nbsp;</strong>This condition can cause a deep y descent due to the stiff ventricular walls allowing rapid passive filling only during early diastole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Constrictive pericarditis:&nbsp;</strong>Similar to restrictive cardiomyopathy, constrictive pericarditis also shows a rapid early diastolic filling as the rigid pericardium constricts ventricular filling in late diastole, leading to a pronounced y descent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Tricuspid regurgitation:&nbsp;</strong>In tricuspid regurgitation, right atrial emptying occurs without the normal resistance posed by a competent tricuspid valve, often resulting in a prominent y descent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In cardiac tamponade, the presence of fluid in the pericardial space restricts all phases of cardiac filling, leading to a blunted or absent y descent, differentiating it from conditions where a deep y descent is observed.</span></p>",
    "correct_choice_id": 46890,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 9897,
    "choices": [
      {
        "id": 39554,
        "text": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">2, 3</span></span></span></p>"
      },
      {
        "id": 39555,
        "text": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">1, 2, 3, 4</span></span></span></p>"
      },
      {
        "id": 39556,
        "text": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">2, 3, 4</span></span></span></p>"
      },
      {
        "id": 39557,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">1, 2</span></span></span></p>"
      }
    ],
    "text": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Membranoproliferative glomerulonephritis is seen in: (</span></span></span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AIIMS </span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">NOV 2020)</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">HIV&nbsp;&nbsp; </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">SLE&nbsp;&nbsp; </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">CLL&nbsp;&nbsp; </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Hepatitis B</span></span></span></li>\r\n</ol>",
    "unique_key": "Q7032603",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449391,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) 1, 2, 3, 4</span></strong> </span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Membranoproliferative glomerulonephritis (MPG) is seen <strong>in HIV, SLE, CLL, and Hepatitis B.</strong></span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">MPGN is caused due to immune-mediated injury. It often presents with a nephritic-nephrotic picture.</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">The causes of MPGN are as follows:</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Primary MPGN (Idiopathic)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Secondary MPGN</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">System lupus erythematosus (<strong>SLE)</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Alpha 1-antitrypsin deficiency</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Infections </span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">- hepatitis B, hepatitis C, HIV, schistosomiasis, endocarditis, infected ventriculoarterial shunts, chronic visceral abscesses</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Malignancies </span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">- chronic lymphocytic leukemia (CLL)</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">MPGN is characterized by the proliferation of cells predominantly in the mesangium and the capillary loops. Hence it is also called mesangiocapillary glomerulonephritis. </span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">There are 2 types of MPGN:</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/1112.jpg\" style=\"height:422px; width:500px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Duplication of the basement membrane gives a double contour or tram-track appearance. It is especially evident in silver or PAS stains.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">MPGN&nbsp;</span></strong><span style=\"font-size:12.0pt\">can be seen in various conditions, including <strong>HIV, SLE, CLL, and Hepatitis B</strong>, making it important to consider these diseases in the differential diagnosis of MPGN</span></span></span></p>\r\n\r\n<p style=\"margin-right:-9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref:&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Robbins and Cotrans pathological basis of disease 8<sup>th</sup> edition pg 1777</span></strong></span></span></p>",
    "correct_choice_id": 39555,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6923,
    "choices": [
      {
        "id": 27660,
        "text": "<p><span style=\"font-size:12.0pt;\">5</span></p>"
      },
      {
        "id": 27661,
        "text": "<p><span style=\"font-size:12.0pt;\">6</span></p>"
      },
      {
        "id": 27662,
        "text": "<p><span style=\"font-size:12.0pt;\">1/5</span></p>"
      },
      {
        "id": 27663,
        "text": "<p><span style=\"font-size:12.0pt;\">1/6</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">After reaching an equilibrium state during exercising, it was found that the body was consuming oxygen at the rate of 1500 ml/min. Calculate the MET score if the baseline oxygen consumption at rest is 250 ml/min? (</span>INICET Nov 2021)</p>",
    "unique_key": "Q4766849",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449081,
    "difficulty_level": "intermediate",
    "subjects_id": [
      2
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 6</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">MET (Metabolic Equivalent) is a unit used to estimate the energy expenditure of physical activities as a multiple of the resting metabolic rate (RMR). One MET is equal to the energy expended at rest, which is approximately 3.5 mL of oxygen per kilogram of body weight per minute (ml/kg/min).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">To calculate the MET score for a given level of oxygen consumption, we need to first convert the oxygen consumption rate from ml/min to ml/kg/min, and then divide it by the resting oxygen consumption rate to get the MET value.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Assuming an average body weight of 70 kg, the oxygen consumption rate of 1500 ml/min corresponds to 21.4 ml/kg/min (1500 ml/min \u00f7 70 kg).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Dividing this value by the resting oxygen consumption rate of 250 ml/min, we get:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">MET score = 21.4 ml/kg/min \u00f7 3.5 ml/kg/min \u2248 6</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Therefore, the correct answer is B. 6.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The MET score represents the energy expenditure of an activity as a multiple of the resting metabolic rate.</span></p>",
    "correct_choice_id": 27661,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 24723,
    "choices": [
      {
        "id": 98853,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cirrhosis</span></span></span></p>"
      },
      {
        "id": 98854,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Creutzfeldt-Jakob disease</span></span></span></p>"
      },
      {
        "id": 98855,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nephritic syndrome</span></span></span></p>"
      },
      {
        "id": 98856,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sickle cell anemia</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following disorders is caused due to abnormal folding of proteins?</span></span> <span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">INICET MAY 2023)</span></span></p>",
    "unique_key": "Q5330460",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449086,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Creutzfeldt-Jakob disease</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Creutzfeldt-Jakob disease is caused due to abnormal folding of proteins.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CREUTZFELDT-JAKOB DISEASE (CJD)</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rare, degenerative, and fatal brain disorder.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Belongs to the group of transmissible spongiform encephalopathies (TSEs).</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Results in the rapid deterioration of neurological function.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Causes</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Abnormal prion proteins (misfolded) accumulate in the brain, leading to nerve cell damage.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Can be sporadic, genetic, or acquired through contaminated medical procedures</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Symptoms</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rapidly progressive dementia.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Muscle stiffness, twitching, and weakness.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Behavioral changes, mood swings, and hallucinations.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Difficulty walking, speaking, and swallowing</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Diagnosis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Based on clinical symptoms, medical history, and neurological examination.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Brain imaging and cerebrospinal fluid analysis to rule out other conditions.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treatment</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">No cure or specific treatment available.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Supportive care to manage symptoms and maintain quality of life.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Cirrhosis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Primarily caused by chronic liver injury due to alcohol abuse, hepatitis, or other liver diseases, and is not related to abnormal protein folding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Nephritic syndrome</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Characterized by inflammation of the glomeruli, leading to hematuria, hypertension, and proteinuria. The condition is generally caused by immune-mediated mechanisms, not by abnormal protein folding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Sickle cell anemia</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: While it is caused by a protein mutation, it is not related to the abnormal folding of proteins.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Creutzfeldt-Jakob disease is a disorder caused by the abnormal folding of prion proteins, leading to severe and fatal brain degeneration.</span></span></span></p>",
    "correct_choice_id": 98854,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11077,
    "choices": [
      {
        "id": 44274,
        "text": "<p><span style=\"font-size:18px;\">Cholera</span></p>"
      },
      {
        "id": 44275,
        "text": "<p><span style=\"font-size:18px;\">Typhoid</span></p>"
      },
      {
        "id": 44276,
        "text": "<p><span style=\"font-size:18px;\">Polio</span></p>"
      },
      {
        "id": 44277,
        "text": "<p><span style=\"font-size:18px;\">Tetanus</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>As a public health expert, you are consulted about a series of outbreaks in a region that lacks significant prior vaccination campaigns. Given the imperative to contain the spread of disease and protect vulnerable populations, you are asked to prioritize a disease for which mass vaccination would provide the most immediate and impactful reduction in transmission. Which of the following diseases would most benefit from such an intervention? </strong><i><strong>[AIIMS MAY 2019]</strong></i></span></p>",
    "unique_key": "Q1161023",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449309,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Polio</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Mass immunization is one of the best strategies to deal with outbreak of poliomyelitis.</span></li><li><span style=\"font-size:18px;\">Outbreak response immunization (ORI): Following the Acute flaccid paralysis case investigation and stool specimen collection, ORI is organized in community.</span></li><li><span style=\"font-size:18px;\">Children aged 0-59 months are given one dose of OPV regardless of previous immunization (in the village/locality of the AFP case)</span></li><li><span style=\"font-size:18px;\">Travel history of the child with AFP may suggest additional places of stay where ORI should also be conducted</span></li><li><span style=\"font-size:18px;\">Atleast 500 children are vaccinated</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Options A. Cholera:&nbsp;</strong>In case of a <strong>cholera</strong> outbreak, the most effective response would be chemoprophylaxis for a household or a closed community and. Drug of choice for chemoprophylaxis is Tetracycline.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Typhoid:</strong> control in case of an outbreak includes health education, water quality and sanitation improvement, prevent carriers from handling food, milk or water from others, and training of health professionals in diagnosis and treatment. Vaccination is not advised for typhoid outbreaks.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Tetanus</strong>: Tetanus is not a communicable disease in the traditional sense as it does not spread from person to person. Instead, it is caused by bacteria entering the body through wounds. Thus, mass vaccination for tetanus isn't typically utilized as an outbreak response but is important in routine immunization schedules.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Polio, due to its potential for rapid spread and severe outcomes, along with the availability of an effective and easily administered vaccine, makes it the most critical focus for a mass vaccination campaign in response to an outbreak.</span></li><li><span style=\"font-size:18px;\">This strategy not only protects individuals but also aids in the global effort to eradicate polio.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Additional Information</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Outbreak response for Measles includes</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-roman;\"><li><span style=\"font-size:18px;\">Isolation for 7 days after the onset of rash</span></li><li><span style=\"font-size:18px;\">Immunization of the contacts within 2 days of exposure (if vaccine is contraindicated, immunoglobulins should be given within 3-4 days of exposure)</span></li><li><span style=\"font-size:18px;\">Prompt immunization at the beginning of an epidemic is essential to limit the spread.</span></li></ol>",
    "correct_choice_id": 44276,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "CriteriaBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 10097,
    "choices": [
      {
        "id": 40354,
        "text": "<p><span style=\"font-size:12.0pt;\">Causes metabolic and enzymatic activity to stop</span></p>"
      },
      {
        "id": 40355,
        "text": "<p><span style=\"font-size:12.0pt;\">Prevents the cells from sticking to the slide surface</span></p>"
      },
      {
        "id": 40356,
        "text": "<p><span style=\"font-size:12.0pt;\">Colors the red cells</span></p>"
      },
      {
        "id": 40357,
        "text": "<p><span style=\"font-size:12.0pt;\">Fixes cells to slide</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">What is the function of Acetone Free Methanol in Leishman stain? (AIIMS MAY 2017)</span></p>",
    "unique_key": "Q8953820",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449296,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Causes metabolic and enzymatic activity to stop</strong></span><br><br><span style=\"font-size:12.0pt;\">Acetone-free methanol serves as a fixing agent in the Leishman stain process. Its primary function is to cause metabolic and enzymatic activity to stop, which preserves cellular architecture. This fixation occurs through protein denaturation and halts all biological processes, maintaining the cellular structure for microscopic examination. Therefore, the correct choice would be: \"Causes metabolic and enzymatic activity to stop.\"</span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The procedure of Leishman stain:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Freshly prepare and rapidly air-dry blood film.</span></li><li><span style=\"font-size:12.0pt;\">Cover the film with Leishman's Stain (S018S) and allow it to act for 1 minute. Methanol in the stain fixes the preparation.</span></li><li><span style=\"font-size:12.0pt;\">Add double the volume of distilled water to the slide and mix.</span></li><li><span style=\"font-size:12.0pt;\">Allow the diluted stain to act for 10-12 minutes.</span></li><li><span style=\"font-size:12.0pt;\">Wash the film with distilled water or phosphate buffer of pH 7.0, drain and dry in air and examine</span></li></ul><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span><br><br><span style=\"font-size:12.0pt;\"><strong>Option B. Prevents the cells from sticking to the slide surface:</strong> This is incorrect because methanol doesn't prevent adhesion; rather, it preserves cellular structure through protein denaturation.</span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Colors the red cells:</strong> This is not the role of acetone-free methanol. The actual coloring of the cells is performed by the dye components in the Leishman stain (methylene blue and eosin).</span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Fixes cells to slide:</strong> While methanol is a fixative, its primary mechanism is stopping metabolic activity, not adhering cells to the slide. As previously noted, adhesion to the slide surface is the function of substances like albumin.</span><br><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Acetone-free methanol in the Leishman stain primarily functions by causing metabolic and enzymatic activity to stop through protein denaturation, which preserves cellular architecture and enables proper staining and microscopic&nbsp;examination.</span></p>",
    "correct_choice_id": 40354,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "InstrumentsBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6955,
    "choices": [
      {
        "id": 27788,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ampicillin</span></span></span></p>"
      },
      {
        "id": 27789,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Co-trimoxazole</span></span></span></p>"
      },
      {
        "id": 27790,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Azithromycin</span></span></span></p>"
      },
      {
        "id": 27791,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chloramphenicol</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An infant of 2 months had a serum bilirubin level of 33 mg/dL. The mother might have taken which of the following drugs during the third trimester for this to occur?&nbsp;&nbsp;&nbsp;&nbsp;</span></span></p>",
    "unique_key": "Q9759540",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449398,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Co-trimoxazole</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Co-trimoxazole is a combination of two antibiotics: trimethoprim and sulfamethoxazole. Sulfamethoxazole is a sulfonamide, which can displace bilirubin from its binding sites on plasma albumin. This displacement increases the free bilirubin levels in the blood, which can cross the blood-brain barrier and potentially lead to kernicterus, a type of brain damage resulting from very high levels of bilirubin in a newborn&#39;s blood.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">When pregnant women take sulfonamides near term, these drugs can cross the placenta and affect the fetus, increasing the risk of hyperbilirubinemia and kernicterus in newborns. Therefore, Co-trimoxazole is contraindicated during the third trimester of pregnancy.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Ampicillin:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Ampicillin is a penicillin antibiotic. It does not displace bilirubin from albumin, and therefore, it is not associated with an increased risk of hyperbilirubinemia or kernicterus in newborns.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Azithromycin:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Azithromycin is a macrolide antibiotic. It is not known to displace bilirubin from albumin and is not associated with an increased risk of hyperbilirubinemia or kernicterus in newborns.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Chloramphenicol:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Chloramphenicol is an antibiotic that can cause gray baby syndrome when given to newborns due to their immature liver enzymes, but it does not typically cause hyperbilirubinemia or kernicterus. It is not known to displace bilirubin from albumin.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Co-trimoxazole, which contains the sulfonamide sulfamethoxazole, can displace bilirubin from plasma albumin, increasing the risk of hyperbilirubinemia and kernicterus in newborns. Therefore, it is contraindicated during the third trimester of pregnancy or during lactation.</span></span></span></p>",
    "correct_choice_id": 27789,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13728,
    "choices": [
      {
        "id": 54873,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Congenital scoliosis</span></p>"
      },
      {
        "id": 54874,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Dextrocardia</span></p>"
      },
      {
        "id": 54875,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Diastematomyelia</span></p>"
      },
      {
        "id": 54876,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Klippel-Feil syndrome</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Sprengel\u2019s deformity associated with all except: (INICET Nov 2017)&nbsp;</span></p>",
    "unique_key": "Q2668427",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449071,
    "difficulty_level": "intermediate",
    "subjects_id": [
      15
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Dextrocardia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>SPRENGEL\u2019S DEFORMITY</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">It consists of <strong>permanent elevation of the shoulder girdle</strong> due to developmental defect.</span></li><li><span style=\"font-size:12.0pt;\">The scapula is smaller in its vertical diameter and appears broad. It lies high in position.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/07/picture25.jpg\" alt=\"\" width=\"250\" height=\"281\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Para scapular muscles are composed of imperfectly developed muscle fibers or fibrous tissue.</span></li><li><span style=\"font-size:12.0pt;\">From the superior angle of scapula a sheet or band-like structure composed of fibrous tissue cartilage or bone extends upwards to attach to the transverse process of several cervical vertebrae known as <strong>Omovertebral bar</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/07/picture26.jpg\" alt=\"\" width=\"300\" height=\"269\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">It is <strong>associated with</strong> <strong>Klippel-Feil Syndrome/Scoliosis/Spina bifida (Diastematomyelia)/Cervical rib</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Clinical Feature:&nbsp;</strong>Shoulder and the scapula at a higher level than the opposite one, restriction of shoulder movement.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Treatment:&nbsp;</strong>There is <strong>no definitive treatment available</strong>. Surgery (Woodward procedure) is done for cosmetic reasons only.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Dextrocardia is rarely associated with Sprengel\u2019s Deformity.&nbsp;</span></p>",
    "correct_choice_id": 54874,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 9966,
    "choices": [
      {
        "id": 39830,
        "text": "<p><span style=\"font-size:12.0pt;\">Esophagitis</span></p>"
      },
      {
        "id": 39831,
        "text": "<p><span style=\"font-size:12.0pt;\">Squamous cell carcinoma</span></p>"
      },
      {
        "id": 39832,
        "text": "<p><span style=\"font-size:12.0pt;\">Adenocarcinoma</span></p>"
      },
      {
        "id": 39833,
        "text": "<p><span style=\"font-size:12.0pt;\">Barrett's esophagus</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old patient presented with heartburn and increased salivation. Upper gastrointestinal endoscopy was done, and the biopsy result is shown below. What is the diagnosis?</span> <span style=\"font-size:12.0pt;\">(AIIMS NOV 2017)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/43.jpg\" alt=\"\" width=\"300\" height=\"209\"></span></p>",
    "unique_key": "Q3061073",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449292,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Barrett\u2019s esophagus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This image indicates the diagnostic features of Barrett's esophagus. Note the transition between esophageal squamous mucosa and Barrett metaplasia, with abundant metaplastic goblet cells.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/05/screenshot-2024-09-05-170620.png\" alt=\"\" width=\"300\" height=\"239\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Barrett's esophagus is a complication of chronic gastroesophageal reflux disease (GERD) characterized by intestinal metaplasia within the esophageal squamous mucosa. It is a premalignant condition that confers an increased risk of esophageal adenocarcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hence, patients diagnosed with Barrett's Esophagus require that periodic endoscopy with biopsy, for detection of dysplasia every 1-2 years to detect dysplasias.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of dysplasia is associated with prolonged symptoms, longer segment length, increased patient age, and Caucasian</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/45.jpg\" alt=\"\" width=\"542\" height=\"475\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Esophagitis:</strong> While esophagitis, inflammation of the esophagus, may be seen in GERD, it does not show the characteristic intestinal metaplasia with goblet cells as seen in Barrett's esophagus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Squamous cell carcinoma:</strong> This type of cancer originates from the squamous cells of the esophagus and does not involve the metaplastic changes characteristic of Barrett's esophagus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Adenocarcinoma:</strong> Adenocarcinoma of the esophagus can develop from Barrett's esophagus, but the histological image provided is more consistent with the premalignant stage of Barrett's esophagus rather than adenocarcinoma itself.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Barrett's esophagus is a premalignant condition marked by intestinal metaplasia with goblet cells within the esophageal squamous mucosa, requiring regular surveillance for dysplasia and potential progression to adenocarcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins pathologic basis of disease, 8<sup>th</sup> edition, Page No. 1464</strong></span></p>",
    "correct_choice_id": 39833,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14053,
    "choices": [
      {
        "id": 56173,
        "text": "<p><span style=\"font-size:12.0pt;\">High inguinal orchidectomy</span></p>"
      },
      {
        "id": 56174,
        "text": "<p><span style=\"font-size:12.0pt;\">Core needle trucut biopsy</span></p>"
      },
      {
        "id": 56175,
        "text": "<p><span style=\"font-size:12.0pt;\">FNAC</span></p>"
      },
      {
        "id": 56176,
        "text": "<p><span style=\"font-size:12.0pt;\">Whole body PET/CT</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 24-year-old male presented with a hard painless testicular swelling. There were no inguinal, intra-abdominal or mediastinal lymph nodes on CT scan. The blood workup showed AFP levels of &gt; 3000. USG shows uniform echotexture with small areas of necrosis. The next line of management is: (AIIMS NOV 2018)</span></p>",
    "unique_key": "Q3228453",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449287,
    "difficulty_level": "beginner",
    "subjects_id": [
      12
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) High inguinal orchidectomy</strong></span><span style=\"font-size:11pt;\"> &nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is the correct choice. In a young male presenting with a hard, painless testicular swelling and significantly elevated AFP levels (&gt;3000), along with findings of uniform echotexture with small areas of necrosis on ultrasound (USG), there is a high suspicion of testicular cancer, particularly a non-seminomatous germ cell tumor (NSGCT). High inguinal orchidectomy is the standard initial surgical approach for the diagnosis and treatment of testicular cancer. The removed testicle is sent for pathological examination to confirm the diagnosis and determine the specific type of tumor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\"><strong>B. Core needle trucut biopsy</strong>: Core needle biopsy is contraindicate for testicular masses because it carries the risk of tumor spread or seeding along the biopsy tract.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>C. FNAC (Fine Needle Aspiration Cytology)</strong>: FNAC is also not the preferred option for testicular masses due to the risk of tumor seeding and difficulties in obtaining an accurate diagnosis for testicular cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12pt;\"><strong>D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Whole body PET/CT</strong>: Whole body PET/CT is typically used for staging and evaluating the extent of cancer after a diagnosis is confirmed. It is not the initial step in diagnosing a testicular mass.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given features that point towards the diagnosis of non-seminomatous germ cell tumor (NSGCT) in stage I of the tumor. In a case of painless swelling of the testis, a testicular tumor should be suspected. The associated rise in AFP level points toward a diagnosis of NSGCT although tissue diagnosis is required to confirm the nature of the tumor. But tissue diagnosis is not a prerequisite for treatment, and hence, based on the available evidence a high inguinal orchidectomy is done in this case. Further treatment is followed up based on the findings of the excisional biopsy.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">NSGCTs are not radiosensitive, but they are highly sensitive to combination chemotherapy with bleomycin, etoposide, and cis-platinum (BEP chemotherapy). Up to 30% of NSGCT patients with stage I disease have subclinical metastases and will relapse if surveillance alone is done after orchidectomy.</span></li><li><span style=\"font-size:12.0pt;\">Accordingly, some NSGCTs with good prognoses can be managed by surveillance protocols (using regular CT scanning and tumor marker measurement), with the more high-risk cases receiving chemotherapy.</span></li><li><span style=\"font-size:12.0pt;\">For NSGCTs a 5-year survival rate of more than 90% is achievable in patients with good prognosis tumors, while for more advanced tumors, the 5-year survival rate is about 60%.</span></li></ul>",
    "correct_choice_id": 56173,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6021,
    "choices": [
      {
        "id": 24054,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Graph A</span></span></span></p>"
      },
      {
        "id": 24055,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">\ufeff\ufeff\ufeffGraph B</span></span></span></p>"
      },
      {
        "id": 24056,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">\ufeff\ufeff\ufeffGraph C</span></span></span></p>"
      },
      {
        "id": 24057,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">\ufeff\ufeff\ufeffGraph D</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following graphs represents normal response to OGTT?&nbsp;</span></span>(INICET MAY 2022)</p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/1_QetTw5P.jpg\" style=\"height:197px; width:300px\" /></span></span></span></span></p>",
    "unique_key": "Q7698609",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449297,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Graph D</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The normal response to an Oral Glucose Tolerance Test (OGTT) is depicted by Graph D. During an OGTT, a patient ingests a specified amount of glucose (commonly 75 grams), and blood glucose levels are measured at intervals to evaluate how well the body handles glucose. In a normal response:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Blood glucose levels rise to a peak within 1 hour after ingestion.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose levels then decline and return to baseline by 2 hours.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The glucose levels do not exceed the renal threshold at any point during the test.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This pattern reflects the body&#39;s effective regulation of blood glucose levels and the normal function of insulin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Graph A:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Graph A might depict an abnormal glucose tolerance curve, such as one seen in impaired glucose tolerance or gestational diabetes, where glucose levels remain elevated for a prolonged period or fail to return to baseline.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Graph B</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Graph B could show a response with an abnormal peak or delayed return to baseline, indicative of glucose intolerance or a diagnostic criterion for diabetes mellitus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Graph C</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Graph C might represent an exaggerated glucose peak or prolonged elevated glucose levels, suggesting a pathological glucose tolerance response consistent with diabetes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A normal OGTT response features a peak in blood glucose levels within 1 hour, followed by a return to baseline levels within 2 hours, without exceeding the renal threshold.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><a href=\"https://www.researchgate.net/publication/301045468_VARIANTS_OF_ORAL_GLUCOSE_TOLERANCE_TEST_OGTT_CURVE_IN_GESTATIONAL_DIABETES_MELLITUS_GDM\" style=\"color:#0563c1; text-decoration:underline\"><strong>https://www.researchgate.net/publication/301045468_VARIANTS_OF_ORAL_GLUCOSE_TOLERANCE_TEST_OGTT_CURVE_IN_GESTATIONAL_DIABETES_MELLITUS_GDM</strong></a></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>",
    "correct_choice_id": 24057,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "INICET",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 76132,
    "choices": [
      {
        "id": 303401,
        "text": "<p><span style=\"font-size:18px;\">6 health functionaries</span></p>"
      },
      {
        "id": 303402,
        "text": "<p><span style=\"font-size:18px;\">6 health beneficiaries</span></p>"
      },
      {
        "id": 303403,
        "text": "<p><span style=\"font-size:18px;\">6 institutional mechanisms&nbsp;</span></p>"
      },
      {
        "id": 303404,
        "text": "<p><span style=\"font-size:18px;\">6 interventions</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\"><strong>All of the following are the components of Anemia Mukt Bharat Programme except: [</strong><i><strong>INICET NOV 2024]</strong></i></span></p>",
    "unique_key": "Q2989298",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449077,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) 6 health functionaries</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Anemia Mukt Bharat</strong> (AMB) or Intensified Iron Plus Initiative launched in 2018 uses a strategic framework called the <strong>6x6x6 strategy</strong>.&nbsp;</span></li><li><span style=\"font-size:18px;\">This includes <strong>6 beneficiaries, 6 interventions, and 6 institutional mechanisms.</strong>&nbsp;</span></li><li><span style=\"font-size:18px;\">The program does not include <strong>\"6 health functionaries</strong>\" as a component.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>The 6x6x6 strategy includes:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>1. 6 beneficiaries:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:18px;\">Children aged 6-59 months</span></li><li><span style=\"font-size:18px;\">Children aged 5-9 years</span></li><li><span style=\"font-size:18px;\">Adolescents aged 10-19 years</span></li><li><span style=\"font-size:18px;\">Women of reproductive age (20-49 years, non-pregnant, non-lactating)</span></li><li><span style=\"font-size:18px;\">Pregnant women</span></li><li><span style=\"font-size:18px;\">Lactating women</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>2. 6 interventions:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:18px;\">Iron and folic acid supplementation</span></li><li><span style=\"font-size:18px;\">Deworming (biannually with albendazole)</span></li><li><span style=\"font-size:18px;\">Behavior change communication</span></li><li><span style=\"font-size:18px;\">Iron fortified foods</span></li><li><span style=\"font-size:18px;\">Testing and treatment of anemia</span></li><li><span style=\"font-size:18px;\">Increasing awareness about non-nutritional causes of anemia</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>3. 6 institutional mechanisms for program implementation and monitoring</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:18px;\">The main aim of the Anemia Mukt Bharat program is to reduce the prevalence of anemia by 3 percentage points per year among children, adolescents, and women in the reproductive age group (15-49 years) between 2018-2022.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The Anemia Mukt Bharat program follows a <strong>6x6x6 strategy which includes 6 beneficiaries, 6 interventions, and 6 institutional mechanisms,</strong> but does not include 6 health functionaries.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-30%20135420.jpg\" width=\"908\" height=\"278\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>IFA TABLETS [Anemia Mukt Bharat]</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_loMbys3.png\" width=\"1128\" height=\"151\"></strong></span></p>",
    "correct_choice_id": 303401,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6733,
    "choices": [
      {
        "id": 26901,
        "text": "<p><span style=\"font-size:12.0pt;\">Rods and cones</span></p>"
      },
      {
        "id": 26902,
        "text": "<p><span style=\"font-size:12.0pt;\">Ganglion cells</span></p>"
      },
      {
        "id": 26903,
        "text": "<p><span style=\"font-size:12.0pt;\">Cells in lateral geniculate body</span></p>"
      },
      {
        "id": 26904,
        "text": "<p><span style=\"font-size:12.0pt;\">Bipolar cells</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which is the first-order neuron in the optic pathway? (</span>AIIMS May 2019)</p>",
    "unique_key": "Q2035606",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449065,
    "difficulty_level": "beginner",
    "subjects_id": [
      2
    ],
    "solution": "<p><strong>Ans. A) Rods and cones</strong></p><p>&nbsp;</p><ul><li>The rods and cones act as the first-order neurons They give the signals to the bipolar cells act as second order neurons in the optic pathway. They serve as an intermediate link between the photoreceptor cells and the ganglion cells (option B), which are the third-order neurons.</li><li>The electrical signals from the bipolar cells are further transmitted to the ganglion cells. The axons of ganglion cells form the optic nerve, which carries visual information from the retina to the visual processing centers in the brain.</li><li>The optic nerve fibers project to different regions of the brain, including the lateral geniculate body (option C), which is part of the thalamus and is involved in visual processing. Therefore, the correct correct answer is A.</li></ul><p>&nbsp;</p><p><strong>Other Options</strong></p><p>&nbsp;</p><p><strong>Option B. Ganglion cells:</strong>&nbsp;Incorrect. Ganglion cells are the third-order neurons in the optic pathway.</p><p>&nbsp;</p><p><strong>Option C. Cells in lateral geniculate body:</strong>&nbsp;Incorrect. These cells are involved in the later stages of visual processing and are not first-order neurons.</p><p>&nbsp;</p><p><strong>Option D. Bipolar cells:</strong>&nbsp;Incorrect. Bipolar cells are the second-order neurons in the optic pathway.</p><p>&nbsp;</p><p><strong>Educational Objective</strong></p><p>&nbsp;</p><p>In the optic pathway, the first-order neurons are the photoreceptor cells, specifically rods and cones, which convert light into electrical signals. These signals are then relayed through bipolar cells to ganglion cells, whose axons form the optic nerve, ultimately transmitting visual information to the brain.</p>",
    "correct_choice_id": 26901,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 24726,
    "choices": [
      {
        "id": 98865,
        "text": "<p><span style=\"font-size:12.0pt;\">Histiocytes</span></p>"
      },
      {
        "id": 98866,
        "text": "<p><span style=\"font-size:12.0pt;\">Birbeck granules</span></p>"
      },
      {
        "id": 98867,
        "text": "<p><span style=\"font-size:12.0pt;\">Eosinophils</span></p>"
      },
      {
        "id": 98868,
        "text": "<p><span style=\"font-size:12.0pt;\">Giant cells</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient displaying lytic lesions on the skull is being considered for a diagnosis of Langerhans cell histiocytosis. What represents a distinctive discovery on electron microscopy among the following options?</span> <span style=\"font-size:11.0pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2023)</span></p>",
    "unique_key": "Q5983633",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449302,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Birbeck granules</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of Birbeck granules in the cytoplasm is a characteristic finding of Langerhans cell histiocytosis (LCH) on electron microscopy.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/03/screenshot-2024-09-03-170927.png\" alt=\"\" width=\"1000\" height=\"346\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/11/whatsapp-image-2023-07-04-at-125673.jpg\" alt=\"\" width=\"700\" height=\"349\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Histiocytes:</strong> While Langerhans cells are a type of histiocyte, the presence of histiocytes alone is not specific to LCH. The defining feature is the presence of Birbeck granules.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Eosinophils:</strong> Eosinophils are often present in LCH lesions, especially in eosinophilic granuloma, but they are not a distinctive finding on electron microscopy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Giant cells:</strong> Giant cells may be present in a variety of inflammatory or granulomatous conditions, but they are not specific to LCH.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of Birbeck granules on electron microscopy is a distinctive and pathognomonic finding in Langerhans cell histiocytosis.</span></p>",
    "correct_choice_id": 98866,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "INICET",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 12844,
    "choices": [
      {
        "id": 51338,
        "text": "<p><span style=\"font-size:12.0pt;\">Within 72 hours</span></p>"
      },
      {
        "id": 51339,
        "text": "<p><span style=\"font-size:12.0pt;\">Within 36 hours</span></p>"
      },
      {
        "id": 51340,
        "text": "<p><span style=\"font-size:12.0pt;\">Within 5 days</span></p>"
      },
      {
        "id": 51341,
        "text": "<p><span style=\"font-size:12.0pt;\">Within 48 hours</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A rape victim is brought to the casualty of a government hospital for examination. Within what time should a vaginal swab be taken to look for the presence of spermatozoa? (</span>AIIMS Nov 2018)</p>",
    "unique_key": "Q6298354",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449097,
    "difficulty_level": "beginner",
    "subjects_id": [
      10
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Within 72 hours</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Spermatozoa can be demonstrated only if a vaginal swab is taken within 72 hours of an assault.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Semen can be demonstrated on evidence on the outside of the body and on materials such as clothing upto 96 hours.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Presence of spermatozoa and other microorganisms</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">\u2022Spermatozoa remain motile in the vagina for 6-8 hours, occasionally up to 12 hours.</span></p><p><span style=\"font-size:12.0pt;\">\u2022Nonmotile forms can be detected for about 24 hours, rarely up to 48-72 hours.</span></p><p><span style=\"font-size:12.0pt;\">\u2022Detection involves aspirating vaginal contents and examining under a microscope.</span></p><p><span style=\"font-size:12.0pt;\">\u2022Motile sperms suggest recent intercourse; nonmotile sperms indicate a broader time frame (12-72 hours).</span></p><p><span style=\"font-size:12.0pt;\">\u2022Intact spermatozoa are rarely found in the vagina after 72 hours.</span></p><p><span style=\"font-size:12.0pt;\">\u2022Seminal fluid detection from vasectomized males requires prostatic acid phosphatase demonstration.</span></p><p><span style=\"font-size:12.0pt;\">\u2022P30, a semen-specific glycoprotein, is used as a screening test, detectable in vaginal fluid for about 27 hours.</span></p>",
    "correct_choice_id": 51338,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7058,
    "choices": [
      {
        "id": 28200,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treatment of migraine</span></span></span></p>"
      },
      {
        "id": 28201,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treatment of Lennox Gastaut syndrome</span></span></span></p>"
      },
      {
        "id": 28202,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Prophylaxis of ADHD</span></span></span></p>"
      },
      {
        "id": 28203,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treatment of dementia</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Topiramate is used for? (</span></span>INICET May 2021</p>",
    "unique_key": "Q1421831",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449394,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Treatment of Lennox Gastaut syndrome</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Topiramate is an antiepileptic drug that can be used for the treatment of Lennaux-Gestaut Syndrome (characterized by multifocal seizures, having &lt;2.5 Hz spike and wave pattern in EEG). It primarily works by blocking the Na<sup>+</sup> channels, and to some extent it also enhances the GABA receptor currents and limiting the activation of the AMPA-kainate subtype of glutamate receptors.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Topiramate can also be used for:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Decreasing the <strong>C</strong>raving of alcohol</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">O</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Obesity</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">M</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Migraine Prophylaxis (not treatment)</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Bipolar disorder.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">So, among the given options, best answer is Lennox Gastaut syndrome. Do not get confused with migraine as the options specifically mentions the treatment of migraine whereas topiramate is used for prophylaxis of migraine.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Treatment of migraine</strong>: Topiramate is used for the prophylaxis of migraines, not for the acute treatment of migraine attacks.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Prophylaxis of ADHD</strong>: Topiramate is not indicated for the prophylaxis or treatment of ADHD.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Treatment of dementia</strong>: Topiramate is not used for the treatment of dementia.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Topiramate is primarily used for the treatment of Lennox-Gastaut syndrome, a severe form of epilepsy in children. It is also used for the prophylaxis of migraines, reducing alcohol cravings, aiding in weight loss, and as an adjunct therapy for bipolar disorder.</span></span></span></p>",
    "correct_choice_id": 28201,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14040,
    "choices": [
      {
        "id": 56121,
        "text": "<p><span style=\"font-size:14.0pt;\">Adjuvant radiotherapy</span></p>"
      },
      {
        "id": 56122,
        "text": "<p><span style=\"font-size:14.0pt;\">Adjuvant chemotherapy</span></p>"
      },
      {
        "id": 56123,
        "text": "<p><span style=\"font-size:14.0pt;\">Follow up 6 monthly for 2 years and then yearly follow up</span></p>"
      },
      {
        "id": 56124,
        "text": "<p><span style=\"font-size:14.0pt;\">Trastuzumab therapy</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:18px;\">A 63-year-old female patient presented with a 5x1 cm lump in the left upper outer quadrant, with no axillary lymph node involvement. Mammography revealed BIRADS 4b staging. She underwent breast conservation surgery, and the final HE reports showed high nuclear grade DCIS with 7 mm margin clearance. What is the further management? (INICET MAY 2021)</span></p>",
    "unique_key": "Q7333775",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449084,
    "difficulty_level": "intermediate",
    "subjects_id": [
      12
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. A) Adjuvant radiotherapy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">After breast-conserving surgery (BCS) for ductal carcinoma in situ (DCIS), adjuvant radiotherapy is typically recommended. Radiotherapy has been shown to significantly reduce the risk of local recurrence after BCS for DCIS. In this patient, despite having a 7 mm margin clearance, the presence of high nuclear grade DCIS warrants the use of adjuvant radiotherapy to minimize the risk of local recurrence.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B.</strong>&nbsp;<strong>Adjuvant chemotherapy</strong>: Chemotherapy is primarily used for invasive breast cancers, especially when there is a high risk of systemic spread. DCIS is a non-invasive form of breast cancer, and hence systemic chemotherapy is not typically indicated.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C.</strong>&nbsp;<strong>Follow up 6 monthly for 2 years and then yearly follow up</strong>: Regular follow-up is crucial for any patient who has undergone treatment for breast cancer, but it is not the primary management strategy immediately after surgery for high nuclear grade DCIS.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Trastuzumab therapy</strong>: Trastuzumab is a targeted therapy used for HER2-positive invasive breast cancers. DCIS that is HER2-positive does not typically receive trastuzumab therapy, as the benefits of such treatment in non-invasive cancer have not been clearly established.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Based on the Van Nuys prognostic index, the patient\u2019s score is: High grade- 3 points, Margins 7 mm-2 points, Size 5 cm- 3 points and age 63 years- 1 point= 9 points.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The recommended next step in the patient's management would be adjuvant radiotherapy for scores 7 to 9.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/10/screenshot-2024-09-10-182123.png\" alt=\"\" width=\"1000\" height=\"273\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Score: 4 to 6: wide excision alone</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">7 to 9: Adjuvant radiotherapy</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">10 to 12: Mastectomy</span></p>",
    "correct_choice_id": 56121,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 9799,
    "choices": [
      {
        "id": 39163,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Angiolymphoma</span></span></span></p>"
      },
      {
        "id": 39164,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hodgkin&#39;s lymphoma</span></span></span></p>"
      },
      {
        "id": 39165,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IgG4-related disease</span></span></span></p>"
      },
      {
        "id": 39166,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Castleman disease</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presents with abdominal distension and intermittent fever. Peripheral smear findings are normal. A tumor is resected and the histopathology image of the resected lymph node is shown below. What is the most probable diagnosis? (AIIMS NOV 2018)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/943.jpg\" style=\"height:191px; width:300px\" /></span></span></p>",
    "unique_key": "Q4879565",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449397,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Castleman disease</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The given clinical scenario and histopathological image showing follicular hyperplasia of lymph nodes are suggestive of <strong>Castleman disease.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Castleman disease (angiofollicular lymph node hyperplasia. is a lymphoproliferative disorder that can be <strong>associated with HHV-8</strong> (multicentric Castleman disease or MCD. or idiopathic (unicentric Castleman disease or UCD).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">4 subtypes &ndash; </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol style=\"list-style-type:lower-alpha\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Unicentric CD (UCD. involves a single enlarged lymph node or multiple enlarged lymph nodes within a single lymph node region that demonstrate CD-like features under the microscope.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Human herpesvirus 8 <strong>(HHV-8)&ndash;associated</strong> multicentric Castleman disease (HHV-8&ndash;associated MCD. involves multiple regions of enlarged lymph nodes.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">POEMS-associated, HHV-8&ndash;negative MCD</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: POEMS (polyradiculoneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell proliferative disorder, and skin changes) syndrome that co-occurs with HHV-8&ndash;negative MCD</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HHV-8&ndash;negative/<strong>idiopathic</strong> multicentric Castleman disease (iMCD. involves multiple regions of enlarged lymph nodes with CD-like features, flulike illness, abnormal blood counts, and dysfunction of vital organs (see Presentation) due to an unknown cause</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">There are 3 major histological subtypes:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypervascular (UCD) -</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lollipop appearance - atrophic germinal centers with radially penetrating blood vessels</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Onion skin appearance of mantle zone around germinal centers</span></span></span></li>\r\n</ul>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/06/screenshot-2024-09-06-100617.png\" style=\"height:389px; width:500px\" /></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Plasma cell subtype (UCD or MCD - hypertrophic germinal centers, increased vascularity</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mixed variant (MCD. - mix of hypervascular and plasma cell subtype features in the same lymph node</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The clinical features include:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Multiple enlarged lymph nodes</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Night sweats</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Weight loss</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Weakness and fatigue</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hepatosplenomegaly</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">As this condition is associated with elevated levels of IL-6, the treatment involves IL-6 inhibitors like siltuximab and tocilizumab.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Human herpesvirus 8 (HHV8) is a type of herpesvirus that is associated with several diseases, including:</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Kaposi&#39;s sarcoma (KS</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">): HHV8 is the primary cause of KS, a type of cancer that causes the growth of abnormal blood vessels in the skin, mucous membranes, and other organs.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Primary effusion lymphoma (PEL</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">): HHV8 is also associated with PEL, a rare type of cancer that affects immune cells.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Multicentric Castleman disease (MCD</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">): HHV8 is implicated in the development of MCD, a rare disorder of the lymph nodes and related tissues that can cause fever, fatigue, and other symptoms.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HIV-associated lymphomas</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: HHV8 is a co-factor in the development of some types of lymphomas, particularly those that are associated with HIV infection. <strong>E.g.: Plasmablastic lymphoma.</strong></span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is important to note that not all individuals infected with HHV8 will develop these diseases, and other factors, such as genetic susceptibility and immune status, may also play a role in disease development.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Castleman disease</span></strong><span style=\"font-size:12.0pt\"> is a lymphoproliferative disorder characterized by follicular hyperplasia and is associated with HHV-8 in some cases. The treatment involves IL-6 inhibitors due to the elevated IL-6 levels.</span></span></span></p>",
    "correct_choice_id": 39166,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14412,
    "choices": [
      {
        "id": 57609,
        "text": "<p><span style=\"font-size:12.0pt;\">Gastrinoma</span></p>"
      },
      {
        "id": 57610,
        "text": "<p><span style=\"font-size:12.0pt;\">Somatostatinoma</span></p>"
      },
      {
        "id": 57611,
        "text": "<p><span style=\"font-size:12.0pt;\">Insulinoma</span></p>"
      },
      {
        "id": 57612,
        "text": "<p><span style=\"font-size:12.0pt;\">VIPoma</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Out of the options given below the most common pancreatic neuroendocrine tumor (PNET) is:</span> <span style=\"font-size:12.0pt;\">(AIIMS NOV 2019)</span></p>",
    "unique_key": "Q3056057",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449073,
    "difficulty_level": "beginner",
    "subjects_id": [
      12
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Insulinoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Most common type of PNET seen is: Insulinoma</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Insulinomas are the most common type of PNETs. They produce excess insulin, leading to hypoglycemia (low blood sugar) in affected individuals. Insulinomas are typically benign and occur more frequently than other types of PNETs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Gastrinoma</strong>: Gastrinoma is a type of PNET that produces excess gastrin hormone. It is associated with a condition called Zollinger-Ellison syndrome. Gastrinomas are relatively less common than insulinomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B</strong>. <strong>Somatostatinoma</strong>: Somatostatinomas are rare PNETs that produce excess somatostatin hormone. They can occur in the pancreas or other parts of the digestive system. They are less common than insulinomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D.</strong> <strong>VIPoma</strong>: VIPomas, also known as Verner-Morrison syndrome or pancreatic cholera, are PNETs that produce vasoactive intestinal peptide (VIP). These tumors are relatively rare compared to insulinomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">PNETs are a rare type of pancreatic tumor that originate from neuroendocrine cells in the pancreas.</span></li><li><span style=\"font-size:12.0pt;\">PNETs are classified as either functioning or non-functioning based on their ability to produce hormones.</span></li><li><span style=\"font-size:12.0pt;\">Diagnosis of PNETs typically involves imaging studies such as CT or MRI, as well as biopsy or blood tests to measure hormone levels.</span></li><li><span style=\"font-size:12.0pt;\">Treatment options for PNETs may include surgery, chemotherapy, or radiation therapy, depending on the size, location, and type of tumor.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Insulinoma:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The investigation of choice for insulinoma 72-hour fasting glucose and serum insulin levels.</span></li><li><span style=\"font-size:12.0pt;\">Medical management:</span><ul><li><span style=\"font-size:12.0pt;\">Octreotide</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Surgical management - Enucleation</span></li></ul>",
    "correct_choice_id": 57611,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 5878,
    "choices": [
      {
        "id": 23482,
        "text": "<p><span style=\"font-size:12pt;\">Spiegelberg criteria</span></p>"
      },
      {
        "id": 23483,
        "text": "<p><span style=\"font-size:12pt;\">Rubin criteria</span></p>"
      },
      {
        "id": 23484,
        "text": "<p><span style=\"font-size:12pt;\">Studdiford criteria</span></p>"
      },
      {
        "id": 23485,
        "text": "<p><span style=\"font-size:12pt;\">Ring of fire</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following criteria is used for diagnosing abdominal pregnancy?&nbsp;</span>(INICET MAY 2020)</p>",
    "unique_key": "Q2186458",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449305,
    "difficulty_level": "beginner",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Studdiford criteria</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12pt;\"><strong>Studdiford Criteria</strong> is for diagnosis of Primary abdominal pregnancy</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Both tubes and ovaries normal with no marks of injury</span></li><li><span style=\"font-size:12pt;\">Utero-peritoneal fistula should not be seen</span></li><li><span style=\"font-size:12pt;\">The placenta should be attached exclusively to the peritoneal surface</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Spiegelberg Criteria:&nbsp;</strong>Spiegelberg Criteria is for Ovarian ectopic</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The tube on the affected side must be intact</span></li><li><span style=\"font-size:12pt;\">The gestation sac must occupy the position of the ovary</span></li><li><span style=\"font-size:12pt;\">The gestation sac in the ovary must be connected to the uterus by the ovarian ligament</span></li><li><span style=\"font-size:12pt;\">Definite ovarian tissue must be found in the sac wall on histopathology</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Rubin criteria</strong>: Rubin criteria is for Cervical pregnancy</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Ring of fire</strong>: Ring of fire is a sign seen on USG-Color doppler in an unruptured tubal ectopic</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Studdiford Criteria</strong> are used to diagnose primary abdominal pregnancy. This criterion involves:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">Ensuring that both fallopian tubes and ovaries are normal with no signs of injury.</span></li><li><span style=\"font-size:12pt;\">Confirming that no utero-peritoneal fistula is present.</span></li><li><span style=\"font-size:12pt;\">Verifying that the placenta is attached exclusively to the peritoneal surface.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\">These criteria help distinguish primary abdominal pregnancy from other types of ectopic pregnancies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 219, DC Dutta\u2019s Textbook of Obstetrics 8<sup>th</sup> edition.</strong></span></p>",
    "correct_choice_id": 23484,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "CriteriaBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 4091,
    "choices": [
      {
        "id": 16343,
        "text": "<p><span style=\"font-size:12.0pt;\">A, B &amp; C only</span></p>"
      },
      {
        "id": 16344,
        "text": "<p><span style=\"font-size:12.0pt;\">A &amp; B only</span></p>"
      },
      {
        "id": 16345,
        "text": "<p><span style=\"font-size:12.0pt;\">A, B, C &amp; D</span></p>"
      },
      {
        "id": 16346,
        "text": "<p><span style=\"font-size:12.0pt;\">C &amp; D only</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">In which of the following situations will you use a sanitizer? (INICET NOV 2020)</span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:12.0pt;\">Before examining the patient</span></li><li><span style=\"font-size:12.0pt;\">After examining the patient</span></li><li><span style=\"font-size:12.0pt;\">After touching the patient's surroundings</span></li><li><span style=\"font-size:12.0pt;\">Hands are visibly soiled</span></li></ol>",
    "unique_key": "Q6783360",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449068,
    "difficulty_level": "beginner",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) A, B and C only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Healthcare personnel should perform hand hygiene with soap and water when hands are visibly soiled.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Healthcare personnel should use an alcohol-based hand rub for the following clinical indications:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Immediately before touching a patient</span></li><li><span style=\"font-size:12.0pt;\">Before performing an aseptic task (e.g., placing an indwelling device) or handling invasive medical devices</span></li><li><span style=\"font-size:12.0pt;\">Before moving from work on a soiled body site to a clean body site on the same patient</span></li><li><span style=\"font-size:12.0pt;\">After touching a patient or the patient\u2019s immediate environment</span></li><li><span style=\"font-size:12.0pt;\">After contact with blood, body fluids, or contaminated surfaces</span></li><li><span style=\"font-size:12.0pt;\">Immediately after glove removal</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>D. Hands are visibly soiled:</strong> In this case, hand washing with soap and water is recommended rather than using a sanitizer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Healthcare personnel should use hand sanitizer before and after examining a patient and after touching the patient's surroundings. However, when hands are visibly soiled, hand hygiene should be performed using soap and water instead of a sanitizer.</span></p>",
    "correct_choice_id": 16343,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 10405,
    "choices": [
      {
        "id": 41586,
        "text": "<p><span style=\"font-size:12.0pt;\">1</span></p>"
      },
      {
        "id": 41587,
        "text": "<p><span style=\"font-size:12.0pt;\">2</span></p>"
      },
      {
        "id": 41588,
        "text": "<p><span style=\"font-size:12.0pt;\">3</span></p>"
      },
      {
        "id": 41589,
        "text": "<p><span style=\"font-size:12.0pt;\">4</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following marked structure is damaged in respiratory distress syndrome?</span> <span style=\"font-size:12.0pt;\">(INICET NOV 2021)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/113.jpg\" alt=\"\" width=\"300\" height=\"275\"></span></p>",
    "unique_key": "Q6824920",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449075,
    "difficulty_level": "beginner",
    "subjects_id": [
      13
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The structure marked as <strong>2</strong> represents <strong>Type II pneumocytes</strong>, which are crucial in the pathophysiology of respiratory distress syndrome (RDS).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Key Points:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Type I pneumocytes (Marked as 1):</strong> These cells are large and flattened, making up the majority of the alveolar surface area. They form the thin barrier necessary for efficient gas exchange.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Type II pneumocytes (Marked as 2):</strong> These cells are rounded and responsible for producing surfactant, a substance composed of phospholipids and proteins that reduces surface tension within the alveoli. Surfactant is essential for preventing alveolar collapse (atelectasis) during exhalation. In respiratory distress syndrome, especially in premature infants, the deficiency or dysfunction of these Type II cells leads to insufficient surfactant production, causing the alveoli to collapse and resulting in severe breathing difficulties.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Endothelial cells of capillaries (Marked as 3):</strong> These cells line the blood vessels within the lungs and are involved in the exchange of gases between the blood and alveoli. They are not primarily involved in the pathogenesis of RDS.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Red Blood Cells (Marked as 4):</strong> These are the cells responsible for carrying oxygen from the lungs to the rest of the body and returning carbon dioxide to the lungs for exhalation. While essential for overall respiratory function, they are not the site of damage in RDS.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Clinical Relevance:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Respiratory Distress Syndrome (RDS):</strong> Commonly seen in premature infants, RDS is primarily caused by a deficiency of surfactant due to immature Type II pneumocytes. The lack of surfactant leads to increased surface tension, alveolar collapse, and severe respiratory distress. This condition is a leading cause of morbidity and mortality in preterm infants.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Type II pneumocytes are crucial for surfactant production and alveolar stability, and their dysfunction or immaturity is the primary cause of respiratory distress syndrome (RDS) in neonates.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/114.jpg\" alt=\"\" width=\"500\" height=\"242\"></span></p>",
    "correct_choice_id": 41587,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14153,
    "choices": [
      {
        "id": 56573,
        "text": "<p><span style=\"font-size:12.0pt;\">Sudden urge to urinate</span></p>"
      },
      {
        "id": 56574,
        "text": "<p><span style=\"font-size:12.0pt;\">Incontinence while asleep</span></p>"
      },
      {
        "id": 56575,
        "text": "<p><span style=\"font-size:12.0pt;\">Incontinence when patient lies down and coughs</span></p>"
      },
      {
        "id": 56576,
        "text": "<p><span style=\"font-size:12.0pt;\">Incontinence during intercourse</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 37-year-old male comes with lower urinary tract symptoms (LUTS). Which of the following is not a typical presenting LUTS? (INICET NOV 2021)</span></p>",
    "unique_key": "Q5510893",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449301,
    "difficulty_level": "intermediate",
    "subjects_id": [
      12
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Incontinence during intercourse</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">While urinary incontinence during intercourse can occur, it is not considered a typical lower urinary tract symptom (LUTS). LUTS typically encompasses symptoms related to storage and voiding of urine. Incontinence during intercourse might be related to other causes, including psychological factors, or specific conditions impacting the pelvic floor, but it's not a routine symptom when discussing LUTS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Incontinence during sexual activity is not considered a lower urinary tract symptom (LUTS).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>. <strong>Sudden urge to urinate:</strong> This symptom is known as urgency and is a common lower urinary tract symptom. It is the sudden and strong desire to urinate, which can be difficult to delay.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Incontinence while asleep:</strong> This is referred to as nocturnal enuresis or bedwetting. It is a type of urinary incontinence where the patient involuntarily releases urine during sleep. This can be a symptom associated with a variety of conditions, including bladder issues, sleep disorders, or even psychological factors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Incontinence when a patient lies down and coughs:</strong> This is known as stress incontinence. It occurs when physical movement or activity, such as coughing, sneezing, running, or heavy lifting, puts pressure (stress) on the bladder, causing unintentional urine leakage. It's often due to weakened pelvic floor muscles.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">LUTS can be divided into three categories: storage, voiding, and post-micturitional.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Storage LUTS involves the failure of the bladder to act as a urine reservoir, leading to symptoms such as increased frequency of voiding, nocturia, urgency, and urge incontinence.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Voiding LUTS is commonly seen in bladder outlet obstruction and includes symptoms such as hesitancy, reduced stream, and straining.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Post-micturitional LUTS, also caused by bladder outlet obstruction, includes symptoms such as incomplete emptying and post-micturition dribble. Other symptoms of LUTS include stress incontinence, nocturnal enuresis, and strangury.</span></p>",
    "correct_choice_id": 56576,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 63642,
    "choices": [
      {
        "id": 253773,
        "text": "<p><span style=\"font-size:12.0pt;\">Inguinal exploration</span></p>"
      },
      {
        "id": 253774,
        "text": "<p><span style=\"font-size:12.0pt;\">Abdominal exploration</span></p>"
      },
      {
        "id": 253775,
        "text": "<p><span style=\"font-size:12.0pt;\">Scrotal exploration</span></p>"
      },
      {
        "id": 253776,
        "text": "<p><span style=\"font-size:12.0pt;\">No further exploration</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">In a child with a unilateral undescended testis, a diagnostic laparoscopy is performed which shows blind-ending testicular vessels on the right side. What is the next best step?&nbsp;</span></p>",
    "unique_key": "Q8247989",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449088,
    "difficulty_level": "intermediate",
    "subjects_id": [
      12
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) No further exploration</strong></span></p><p><br><span style=\"font-size:16px;\">In cases of non-palpable testis, if laparoscopy reveals blind-ending vas deferens and testicular vessels before entering the internal ring, it confirms a vanishing or absent testis. Hence, no further exploration is necessary. This finding suggests that the testis may have undergone atrophy or vanished in utero.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Cryptorchidism:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Cryptorchidism refers to the failure of descent of the intra-abdominal testes into the scrotal sac. It is the most common congenital abnormality of the genitourinary system.</span></li><li><span style=\"font-size:16px;\">The two phases of testicular descent:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\"><strong>Transabdominal phase</strong>: The testes move to the lower abdomen or pelvis, regulated by Mullerian-inhibiting substances.</span></li><li><span style=\"font-size:16px;\"><strong>Inguinoscrotal phase</strong>: Testes descend through the inguinal canal to the scrotal sac, regulated by androgen-induced calcitonin gene-related peptide from the genitofemoral nerve.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\">Histopathological features of cryptorchidism include:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\"><strong>Testicular atrophy</strong>: Thickening of the basement membrane, arrested germ cell development, and significant hyalinization.</span></li><li><span style=\"font-size:16px;\"><strong>Sertoli cells present but no active spermatogenesis</strong>.</span></li><li><span style=\"font-size:16px;\"><strong>Increased interstitial Leydig cells</strong>.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\">Cryptorchid testes are associated with increased risks, such as testicular atrophy, sterility, and a 3\u20135 times higher risk of testicular cancer (commonly seminoma).</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Inguinal exploration</strong>: Not necessary because blind-ending vessels on laparoscopy indicate no viable testis.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Abdominal exploration and Option C. Scrotal exploration</strong>: Unnecessary for the same reason; the absence of a testis has already been confirmed.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In a child with an undescended testis, if diagnostic laparoscopy reveals blind-ending vas deferens and testicular vessels, it indicates a vanishing testis, and no further surgical exploration is needed.</span></p>",
    "correct_choice_id": 253776,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 23235,
    "choices": [
      {
        "id": 92904,
        "text": "<p><span style=\"font-size:12.0pt;\">Avoid DPT vaccination</span></p>"
      },
      {
        "id": 92905,
        "text": "<p><span style=\"font-size:12.0pt;\">Give DT vaccine</span></p>"
      },
      {
        "id": 92906,
        "text": "<p><span style=\"font-size:12.0pt;\">Give DPT vaccine</span></p>"
      },
      {
        "id": 92907,
        "text": "<p><span style=\"font-size:12.0pt;\">Defer by 4 weeks</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A baby is brought to OPD for 10-week DPT vaccination appointment. He previously experienced a fever exceeding 40\u00b0C and had an inconsolable cry at 6 weeks old after receiving a vaccination. What would be the recommended course of action moving forward? (INICET MAY 2023)</span></p>",
    "unique_key": "Q7801960",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449087,
    "difficulty_level": "intermediate",
    "subjects_id": [
      13
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Give DT vaccine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The child experienced a hypotonic-hyporesponsive episode or severe reaction (fever &gt;40\u00b0C and persistent inconsolable crying) after the previous DPT dose. These are precautionary (not absolute contraindications) for pertussis-containing vaccines like DPT, but they warrant switching to a less reactogenic formulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">DT (Diphtheria + Tetanus) vaccine is recommended in such cases, as it omits the pertussis component, which is most often responsible for such adverse events.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This allows continuation of diphtheria and tetanus protection while avoiding further adverse events from the pertussis component.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Avoid DPT vaccination:</strong> Incorrect. DPT is contraindicated, but not all vaccinations should be avoided. The child should still receive protection against diphtheria and tetanus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Give DPT vaccine:</strong> Incorrect. Given the prior adverse reaction, repeating DPT may risk more serious reactions. It\u2019s prudent to avoid the pertussis component.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Defer by 4 weeks:</strong> Incorrect. There's no benefit in deferring the dose. The issue is not timing but the component that caused the reaction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Severe reactions (such as high fever &gt;40.5\u00b0C, persistent inconsolable crying &gt;3 hours, or hypotonic-hyporesponsive episodes) after a previous DPT dose are indications to withhold the pertussis component in future doses. The child should receive the DT vaccine instead.</span></p>",
    "correct_choice_id": 92905,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44866,
    "choices": [
      {
        "id": 179111,
        "text": "<p style=\"margin-left:4px;\"><span style=\"font-size:12pt;\">Mifepristone</span></p>"
      },
      {
        "id": 179112,
        "text": "<p style=\"margin-left:4px;\"><span style=\"font-size:12pt;\">Cabergoline</span></p>"
      },
      {
        "id": 179113,
        "text": "<p style=\"margin-left:4px;\"><span style=\"font-size:12pt;\">Chlorpromazine</span></p>"
      },
      {
        "id": 179114,
        "text": "<p style=\"margin-left:4px;\"><span style=\"font-size:12pt;\">Metoclopramide</span></p>"
      }
    ],
    "text": "<p style=\"margin-left:4px;text-align:justify;\"><span style=\"font-size:12pt;\">A 30-year-old woman has experienced the loss of her newborn. She is currently producing breast milk, leading to discomfort and the risk of developing a breast abscess due to milk stasis and incomplete emptying. Which of the following drug can be used to prevent this complication? (</span>INICET May 2024)</p>",
    "unique_key": "Q3699515",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449066,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Cabergoline</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In this scenario, the goal is to prevent lactation to avoid discomfort and the risk of developing a breast abscess due to milk stasis and incomplete emptying. The appropriate treatment involves using a drug that can suppress prolactin secretion, as prolactin is the hormone responsible for stimulating milk production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Cabergoline is a dopamine agonist that inhibits prolactin secretion, effectively suppressing lactation. It is often used for this purpose and can be an effective choice in this situation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>A.</strong>&nbsp;<strong>Mifepristone</strong>: Mifepristone is an antiprogestin used for medical termination of pregnancy. It does not have a direct role in suppressing lactation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>C.</strong>&nbsp;<strong>Chlorpromazine</strong>: Chlorpromazine is an antipsychotic medication that can increase prolactin levels, which would not be helpful in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Metoclopramide</strong>: Metoclopramide is a prokinetic agent and antiemetic that also increases prolactin levels, making it unsuitable for suppressing lactation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Given these options, the correct choice for preventing lactation and thus avoiding the associated complications is:&nbsp;<strong>b. Cabergoline</strong></span></p>",
    "correct_choice_id": 179112,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73235,
    "choices": [
      {
        "id": 291897,
        "text": "<p><span style=\"font-size:12.0pt;\">Hearing loss</span></p>"
      },
      {
        "id": 291898,
        "text": "<p><span style=\"font-size:16px;\">Hemodilution</span></p>"
      },
      {
        "id": 291899,
        "text": "<p><span style=\"font-size:12.0pt;\">Thrombosis/Coagulopathy</span></p>"
      },
      {
        "id": 291900,
        "text": "<p><span style=\"font-size:12.0pt;\">Visual disturbance</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">In Decompression sickness, which one of the following is not seen? (INICET NOV 2024)</span></p>",
    "unique_key": "Q5955489",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449079,
    "difficulty_level": "intermediate",
    "subjects_id": [
      2
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Hemodilution</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Decompression sickness (DCS) occurs when a <strong>rapid decrease in ambient pressure</strong> causes <strong>dissolved nitrogen to form bubbles in the tissues and blood vessels</strong>. When divers ascend too quickly from deep water, the dissolved <strong>nitrogen doesn't have time to be eliminated through normal respiration and forms bubbles in various body tissues.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">These nitrogen bubbles cause <strong>vascular damage and endothelial injury,</strong> leading to several pathophysiological changes. One significant effect is capillary leak syndrome, where the plasma extravasates <strong>(leaks out of blood vessels into surrounding tissues).</strong> This extravasation of plasma causes <strong>hemoconcentration</strong> (increased concentration of blood cells) as the fluid component of blood leaves the vessels while the cellular components remain.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">This is precisely why <strong>hemodilution</strong> (the dilution of blood) is <strong>NOT</strong> seen in decompression sickness</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Hearing loss:&nbsp;</strong>This is seen in decompression sickness<strong>.&nbsp;</strong>Nitrogen bubbles can damage the inner ear structures, leading to hearing impairment. The bubbles can affect the cochlea and vestibular apparatus, resulting in hearing loss and balance disturbances.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Thrombosis/Coagulopathy:&nbsp;</strong>This is seen in decompression sickness.<strong>&nbsp;</strong>The endothelial injury caused by nitrogen bubbles activates the coagulation cascade. Additionally, the hemoconcentration leads to stasis of blood flow (Virchow's triad: endothelial injury, stasis, and hypercoagulability), promoting thrombus formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Visual disturbances:&nbsp;</strong>This is seen in decompression sickness. Nitrogen bubbles can damage the retina or affect the rods and cones, leading to various visual impairments. Bubbles can also form in the cerebral circulation affecting visual pathways.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Decompression sickness causes <strong>hemoconcentration </strong>(not hemodilution) due to plasma extravasation resulting from vascular damage caused by nitrogen bubbles.</span></p>",
    "correct_choice_id": 291898,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 24679,
    "choices": [
      {
        "id": 98677,
        "text": "<p><span style=\"font-size:12.0pt;\">Michel aplasia</span></p>"
      },
      {
        "id": 98678,
        "text": "<p><span style=\"font-size:12.0pt;\">Auditory neuropathy</span></p>"
      },
      {
        "id": 98679,
        "text": "<p><span style=\"font-size:12.0pt;\">Malingering</span></p>"
      },
      {
        "id": 98680,
        "text": "<p><span style=\"font-size:12.0pt;\">Cochlear otosclerosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 14-year-old patient arrives at the OPD with a concern about her ability to perceive speech sounds while struggling to comprehend the actual words being spoken. Her Pure Tone Audiometry (PTA) and Brainstem Evoked Response Audiometry (BERA) results show discrepancies, as the PTA is relatively within the normal range. However, her mid-latency and cortical responses are both non-existent. What probable diagnosis can be inferred from these findings? (INICET MAY 2023)</span></p>",
    "unique_key": "Q5879816",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449396,
    "difficulty_level": "intermediate",
    "subjects_id": [
      9
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Auditory neuropathy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">If a child arrives with concerns about not being able to comprehend words, and their BERA (Brainstem Evoked Response Audiometry) results are abnormal while their PTA (Pure Tone Audiometry) results are normal, this could indicate the presence of auditory neuropathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Auditory neuropathy is a neurologic disorder of CN VIII. Audiometric tests, e.g. SNHL for pure tones, impaired speech discrimination score, absent or abnormal auditory brainstem response, show a retrocochlear type of lesion but OAEs are normal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Michel aplasia</strong> also known as&nbsp;complete labyrinthine aplasia,&nbsp;is the most severe congenital&nbsp;inner ear malformation,&nbsp;characterized by complete absence of&nbsp;inner ear structures. This condition would present with profound hearing loss detected on PTA, not normal PTA results.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Malingering:</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Intentional falsification of hearing loss would likely be exposed by objective tests like BERA, which would not show the abnormal results observed in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>Cochlear otosclerosis</strong> shows Carhart\u2019s notch (dip at 2000 Hz in bone conduction) on PTA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Auditory neuropathy should be suspected in patients who present with normal hearing sensitivity on pure tone audiometry but show significant difficulties with speech comprehension and abnormal brainstem evoked response audiometry results.</span></p>",
    "correct_choice_id": 98678,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 10422,
    "choices": [
      {
        "id": 41654,
        "text": "<p><span style=\"font-size:12.0pt;\">Insulin</span></p>"
      },
      {
        "id": 41655,
        "text": "<p><span style=\"font-size:12.0pt;\">Growth hormone</span></p>"
      },
      {
        "id": 41656,
        "text": "<p><span style=\"font-size:12.0pt;\">Thyroxine</span></p>"
      },
      {
        "id": 41657,
        "text": "<p><span style=\"font-size:12.0pt;\">Glucocorticoids</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">The hormone that does not play a role in the growth of the fetus is: (INICET NOV 2022)</span></p>",
    "unique_key": "Q6148651",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449078,
    "difficulty_level": "beginner",
    "subjects_id": [
      13
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Growth hormone.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Fetal growth&nbsp;</strong>is a complex process regulated by various hormones, but <strong>growth hormone</strong> does not play a significant role in this process during fetal life. The primary hormones involved in fetal growth include insulin, thyroxine, and glucocorticoids.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Key Points:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Insulin:&nbsp;</strong>Insulin is crucial for fetal growth, especially during the third trimester. It plays a key role in promoting the storage of nutrients and the growth of fetal tissues, particularly adipose tissue and muscle.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Thyroxine:&nbsp;</strong>Fetal production of thyroxine begins around the 12th week of gestation. Thyroxine is vital for the development of the central nervous system and overall growth and differentiation of tissues.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Glucocorticoids:&nbsp;</strong>Glucocorticoids are essential towards the end of gestation, particularly for the maturation of organs such as the lungs, liver, and gastrointestinal tract. They help prepare the fetus for life outside the womb by stimulating the production of surfactant in the lungs and facilitating the maturation of other critical systems.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Growth Hormone:&nbsp;</strong>Unlike in postnatal life, where growth hormone is a key regulator of growth, its role in fetal growth is minimal. Fetal growth is largely driven by insulin and other growth factors rather than growth hormone.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Insulin and Option C. Thyroxine:&nbsp;</strong>Both are crucial for fetal growth, regulating tissue growth and differentiation, especially in the later stages of pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Glucocorticoids:&nbsp;</strong>These hormones are essential for the maturation of fetal organs before birth, particularly in the liver, lungs, and gastrointestinal tract.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Growth hormone does not play a significant role in fetal growth, which is primarily regulated by insulin, thyroxine, and glucocorticoids.</span></p>",
    "correct_choice_id": 41655,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3520,
    "choices": [
      {
        "id": 14059,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">E.coli</span></span></span></p>"
      },
      {
        "id": 14060,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Pseudomonas</span></span></span></p>"
      },
      {
        "id": 14061,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Haemophilus influenzae</span></span></span></p>"
      },
      {
        "id": 14062,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Actinomyces</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pneumonia caused by a gram-negative pleomorphic bacillus growing on chocolate agar which is catalase and oxidase-positive. Identify the microorganism.</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:10.5pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">INICET MAY 2020)</span></span></p>",
    "unique_key": "Q4638171",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449308,
    "difficulty_level": "beginner",
    "subjects_id": [
      6
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Haemophilus influenzae </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Findings are suggestive of Hemophilus influenza.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hemophilus influenza &ndash; </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Slender, short, <strong>gram negative rods or coccobacillus</strong></span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Non-Motile</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">, no flagella or pilli</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Capsules&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">are present and important in pathogenicity.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Encapsulated form are coccobacilli, CSF Sample</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Non-Capsulated are pleomorphic, long, thread, filamentous</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fastidious Microorganism</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Culture:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Blood Agar: translucent, low, convex or flat pin point colonies, <strong>Satellitism.</strong></span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chocolate Agar: Grayish, Transparent, smooth, low, convex or flat with a slightly splayed out, entire edge, mucoid, pale</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In liquid medium like Levinthal&rsquo;s Broth or Filde&rsquo;s Broth: Uniform Turbidity.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hemophilus influenzae biochemical reactions-</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/28/screenshot-2024-06-28-185008.png\" style=\"height:479px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Haemophilus influenzae can cause many kinds of infections. Which can range from mild ear infections to severe diseases, like meningitis. Haemophilus influenzae bacteria most often cause pneumonia, bacteremia, and meningitis mostly in infants and children younger than five years of age.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>E. coli</strong>: Although it can cause pneumonia, <em>E. coli</em> is typically a gram-negative rod that grows on MacConkey agar and is not usually pleomorphic. It is catalase-positive but not typically grown on chocolate agar.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Pseudomonas</strong>: This genus includes <em>Pseudomonas aeruginosa</em>, which is a gram-negative rod that grows on various media, including nutrient agar and MacConkey agar. It is oxidase-positive but does not typically present as pleomorphic.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Actinomyces</strong>: This is a gram-positive bacterium and not relevant to this question as it does not fit the gram-negative description.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Haemophilus influenzae</span></em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is a gram-negative pleomorphic bacillus that grows on chocolate agar and is catalase and oxidase-positive. It is a common cause of respiratory infections, including pneumonia, particularly in young children.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Additional Information</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/1-micro-36.jpg\" style=\"height:730px; width:1000px\" /></span></span></span></p>",
    "correct_choice_id": 14061,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73648,
    "choices": [
      {
        "id": 293533,
        "text": "<p><span style=\"font-size:12.0pt;\">T cell receptor and MHC II</span></p>"
      },
      {
        "id": 293534,
        "text": "<p><span style=\"font-size:12.0pt;\">CD28 and CD80</span></p>"
      },
      {
        "id": 293535,
        "text": "<p><span style=\"font-size:12.0pt;\">PD-PDL1</span></p>"
      },
      {
        "id": 293536,
        "text": "<p><span style=\"font-size:12.0pt;\">Cytokine secretion</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">All of the following interactions between T cells and APC (Antigen-Presenting Cell) are required for T cell activation/differentiation except: (INICET NOV 2024)</span></p>",
    "unique_key": "Q6399778",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449082,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) PD-PDL1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">PD-PDL1 interaction inhibits <strong>T cell activation and causes T cell exhaustion</strong>. It represents an immune checkpoint that suppresses T cell responses. This interaction is exploited by tumor cells to evade immune surveillance.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. T cell receptor and MHC II&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">This is a crucial <strong>first signal 1 (Antigen recognition)</strong> required for T cell activation</span></li><li><span style=\"font-size:16px;\"><strong>TCR</strong> recognize antigen presented by MHC molecules on APCs for initial activation</span></li><li><span style=\"font-size:16px;\"><strong>CD4+ T cells</strong> recognize <strong>MHC class II</strong> molecules, while <strong>CD8+ T cells</strong> recognize <strong>MHC class I</strong> molecules.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. CD28 and CD80&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">This acts as the essential <strong>co-stimulatory signal</strong> <strong>(Signal 2)</strong></span></li><li><span style=\"font-size:16px;\">Without this second signal, T cells become anergic rather than activated</span></li><li><span style=\"font-size:16px;\">CD28 on T cells interacts with B7 molecules (CD80/86) on APCs</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D.&nbsp;Cytokine secretion</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Cytokine secretion is essential for <strong>T cell differentiation.</strong></span></li><li><span style=\"font-size:16px;\">When there is interaction between <strong>CD40 of B cell with CD40 ligand of T cell</strong>, it leads to secretion of cytokines like <strong>IL-4 and IL-5</strong> which are crucial for T cell differentiation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">PD-PDL1 interaction is an inhibitory checkpoint that causes <strong>T cell exhaustion</strong> rather than activation. This pathway is important in cancer immunotherapy where checkpoint inhibitors are used to prevent tumor immune evasion.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_xUHeUTD.png\" width=\"1421\" height=\"624\"></p>",
    "correct_choice_id": 293535,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 43277,
    "choices": [
      {
        "id": 172775,
        "text": "<p><span style=\"font-size:12.0pt;\">Axillary lymph node status</span></p>"
      },
      {
        "id": 172776,
        "text": "<p><span style=\"font-size:12.0pt;\">Size</span></p>"
      },
      {
        "id": 172777,
        "text": "<p><span style=\"font-size:12.0pt;\">Distant metastasis</span></p>"
      },
      {
        "id": 172778,
        "text": "<p><span style=\"font-size:12.0pt;\">Hormonal status</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Most important prognostic factor for Ca Breast is: (INICET Nov 2023)</span></p>",
    "unique_key": "Q5452663",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449298,
    "difficulty_level": "beginner",
    "subjects_id": [
      12
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Axillary lymph node status</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Positive axillary lymph node involvement usually indicates a higher chance of recurrence and a poorer prognosis compared to no lymph node involvement. The number of affected lymph nodes also plays a crucial role in staging the cancer, which directly impacts treatment options and outcomes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Size of the tumor:</strong> Generally, the larger the tumor, the worse the prognosis because a larger tumor size often correlates with a more advanced stage of cancer. Tumor size is considered when staging breast cancer, with larger tumors often requiring more aggressive treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Distant metastasis:</strong> The presence of distant metastases (stage IV breast cancer) generally indicates a much poorer prognosis because it suggests that the cancer is more aggressive and widespread.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hormonal status:</strong> The hormonal status of the tumor (estrogen receptor (ER) and progesterone receptor (PR) positive or negative) influences both the prognosis and the treatment options. Hormone receptor-positive tumors are often less aggressive and more likely to respond to hormone therapy compared to hormone receptor-negative tumors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">While all these factors are important in assessing the prognosis of breast cancer, the status of the axillary lymph nodes is traditionally considered a key indicator due to its implications for the spread of the disease within the body and potential treatment strategies.&nbsp;</span></p>",
    "correct_choice_id": 172775,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74707,
    "choices": [
      {
        "id": 297741,
        "text": "<p><span style=\"font-size:16px;\">Pachytene</span></p>"
      },
      {
        "id": 297742,
        "text": "<p><span style=\"font-size:16px;\">Prophase</span></p>"
      },
      {
        "id": 297743,
        "text": "<p><span style=\"font-size:16px;\">Leptotene</span></p>"
      },
      {
        "id": 297744,
        "text": "<p><span style=\"font-size:16px;\">Metaphase</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">The primary oocyte is arrested in: (INICET NOV 2024)</span></p>",
    "unique_key": "Q7282823",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449089,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Prophase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In oogenesis, the primary oocyte is arrested in <strong>prophase of meiosis I. specifically the diplotene stage.&nbsp;</strong>This arrest occurs before birth and continues until puberty. The primary oocytes are formed when primordial germ cells undergo mitosis. These primary oocytes then <strong>enter meiosis I but get arrested in prophase I.</strong> This arrested state continues until puberty, when hormonal changes trigger the resumption of meiosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Pachytene:&nbsp;</strong>This is incorrect. While pachytene is a sub-stage of prophase I, the question asks for the main phase of arrest, which is prophase.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Leptotene:&nbsp;</strong>This is incorrect. Like pachytene, leptotene is also a sub-stage of prophase I, not the main phase where arrest occurs.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D: Metaphase:&nbsp;</strong>The secondary oocyte arrests in metaphase 2.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Primary oocytes are arrested in prophase of meiosis I from fetal life until puberty. This arrest is a crucial event in female reproductive development and understanding of oogenesis.</span></p>",
    "correct_choice_id": 297742,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73124,
    "choices": [
      {
        "id": 291457,
        "text": "<p><span style=\"font-size:16px;\">Streptococcus pyogenes&nbsp;</span></p>"
      },
      {
        "id": 291458,
        "text": "<p><span style=\"font-size:16px;\">Staphylococcus aureus&nbsp;</span></p>"
      },
      {
        "id": 291459,
        "text": "<p><span style=\"font-size:16px;\">Enterococcus&nbsp;</span></p>"
      },
      {
        "id": 291460,
        "text": "<p><span style=\"font-size:16px;\">Micrococcus</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">A 20- year male had a pustule which rapidly progressed to necrotizing fascitis. On microscopy findings were seen. What is the most likely organism involved in this case? </span><span style=\"font-size:12.0pt;\">(INICET NOV 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_aZPJuqv.png\" width=\"580\" height=\"289\"></span></p>",
    "unique_key": "Q7533912",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449310,
    "difficulty_level": "beginner",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Streptococcus pyogenes</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The diagnosis of Streptococcus pyogenes is supported by:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\">Clinical presentation: Pustule rapidly progressing to necrotizing fasciitis</span></li><li><span style=\"font-size:16px;\">Microscopy findings: <strong>Gram-positive cocci arranged in chains</strong></span></li><li><span style=\"font-size:16px;\"><strong>Necrotizing fasciitis</strong> is most commonly caused by <strong>Streptococcus pyogenes</strong> (Group A Streptococcus), followed by Staphylococcus aureus</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Staphylococcus aureus:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">While it can cause necrotizing fasciitis, it appears as <strong>gram-positive cocci in clusters</strong></span></li><li><span style=\"font-size:16px;\">Not consistent with the chain arrangement seen in the microscopy image</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Enterococcus:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Appears as <strong>gram-positive cocci</strong> in pairs</span></li><li><span style=\"font-size:16px;\">Not typically associated with <strong>necrotizing fasciitis</strong></span></li><li><span style=\"font-size:16px;\">More commonly causes <strong>urinary tract infections and endocarditis</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Micrococcus:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Appears as gram-positive cocci in tetrads</span></li><li><span style=\"font-size:16px;\">Not a common pathogen</span></li><li><span style=\"font-size:16px;\">Rarely causes human infections</span></li><li><span style=\"font-size:16px;\">Usually a contaminant</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Streptococcus pyogenes (Group A Streptococcus):</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\">Is the most common cause of <strong>necrotizing fasciitis</strong></span></li><li><span style=\"font-size:16px;\">Appears microscopically as <strong>gram-positive cocci</strong> in chains</span></li><li><span style=\"font-size:16px;\">Can progress rapidly from a superficial infection to deep tissue involvement</span></li></ol>",
    "correct_choice_id": 291457,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16052,
    "choices": [
      {
        "id": 64168,
        "text": "<p><span style=\"font-size:12.0pt;\">B</span></p>"
      },
      {
        "id": 64169,
        "text": "<p><span style=\"font-size:12.0pt;\">A</span></p>"
      },
      {
        "id": 64170,
        "text": "<p><span style=\"font-size:12.0pt;\">D</span></p>"
      },
      {
        "id": 64171,
        "text": "<p><span style=\"font-size:12.0pt;\">F</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which part of this bone is palpable in the infraclavicular fossa: (INICET Nov 2021)</span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/18/ai-6.jpg\" alt=\"\" width=\"250\" height=\"272\"></span></p>",
    "unique_key": "Q2609276",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449290,
    "difficulty_level": "beginner",
    "subjects_id": [
      3
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The coracoid process is palpable in the infraclavicular fossa and is marked on the scapula as B. The coracoid process's tip is located approximately 2.5 cm below the clavicle, immediately lateral to the infraclavicular fossa (deltopectoral triangle). As a result, the coracoid process can be palpated below the clavicle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The coracoid process arises from the upper border of the neck of the scapula and it projects forwards and slightly laterally. Attachments at the coracoid process include</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The conoid portion of the coracoclavicular ligament</span></li><li><span style=\"font-size:12.0pt;\">Pectoralis minor</span></li><li><span style=\"font-size:12.0pt;\">Medial end of coraco-acromial ligament</span></li><li><span style=\"font-size:12.0pt;\">Coracohumeral ligament</span></li><li><span style=\"font-size:12.0pt;\">Glenocorocoidligamnet</span></li><li><span style=\"font-size:12.0pt;\">Coracobrachialis muscle</span></li><li><span style=\"font-size:12.0pt;\">Medial end of coraco-acromial ligament</span></li><li><span style=\"font-size:12.0pt;\">Coracohumeral ligament</span></li><li><span style=\"font-size:12.0pt;\">Glenocorocoidligamnet</span></li><li><span style=\"font-size:12.0pt;\">Coracobrachialis muscle</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Acromian process</strong> continues from the spine of the scapula. The acromion is subcutaneous over its dorsal surface, The attachments at the acromion are the coracoacromial ligament, the articular capsule of the acromioclavicular joint, and horizontal fibers of the trapezius.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. The glenoid fossa</strong> is present at the lateral angle of the scapula. It is articular with the humerus to form the shoulder joint.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. The inferior angle</strong> lies over the seventh rib. Dorsally, it is related to latissimus dorsi. The angle is visible when the arm is raised over the head.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"background-color:white;color:#0d0d0d;font-size:11pt;\">The coracoid process is a palpable landmark in the infraclavicular fossa, important for clinical examination and as a reference point for various shoulder procedures. Its recognition is crucial in the assessment of shoulder pathologies and for orientation during surgical approaches to the shoulder.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/18/ai-7.jpg\" alt=\"\" width=\"600\" height=\"240\"></span></p>",
    "correct_choice_id": 64168,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73125,
    "choices": [
      {
        "id": 291461,
        "text": "<p><span style=\"font-size:16px;\">Lowenstein-jensen medium</span></p>"
      },
      {
        "id": 291462,
        "text": "<p><span style=\"font-size:16px;\">Macconkey agar&nbsp;</span></p>"
      },
      {
        "id": 291463,
        "text": "<p><span style=\"font-size:16px;\">Sabouraud dextrose agar</span></p>"
      },
      {
        "id": 291464,
        "text": "<p><span style=\"font-size:16px;\">Muller hinton</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Mycobacterium tuberculosis is typically cultured in which medium? (INICET NOV 2024)</span></p>",
    "unique_key": "Q2617644",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449303,
    "difficulty_level": "intermediate",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Lowenstein-Jensen medium</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Mycobacterium tuberculosis requires a special medium for growth and cannot grow on routine culture media. <strong>Lowenstein-Jensen (LJ) medium</strong> is the standard and most commonly used medium for culturing M. tuberculosis. This medium contains:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Coagulated egg proteins</span></li><li><span style=\"font-size:16px;\">Glycerol</span></li><li><span style=\"font-size:16px;\">Asparagine</span></li><li><span style=\"font-size:16px;\">Potato flour</span></li><li><span style=\"font-size:16px;\">Mineral salts: The medium provides essential nutrients and supports the slow growth of mycobacteria over 3-8 weeks.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Macconkey agar: Incorrect&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">This medium is used for growing and differentiating Gram-negative enteric bacteria</span></li><li><span style=\"font-size:16px;\">It contains bile salts and crystal violet which inhibit Gram-positive bacteria</span></li><li><span style=\"font-size:16px;\">M. tuberculosis cannot grow on this medium</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Sabouraud dextrose agar: Incorrect</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">This is a selective medium used for isolating fungi</span></li><li><span style=\"font-size:16px;\">Its acidic pH and high glucose concentration make it unsuitable for bacterial growth</span></li><li><span style=\"font-size:16px;\">M. tuberculosis requires more complex nutrients not present in this medium</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Mueller-Hinton agar: Incorrect</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">This is a non-selective medium primarily used for antibiotic susceptibility testing</span></li><li><span style=\"font-size:16px;\">It lacks the specific nutrients required for mycobacterial growth</span></li><li><span style=\"font-size:16px;\">The growth time required by M. tuberculosis is too long for this medium</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">M. tuberculosis requires specific growth conditions and must be cultured on Lowenstein-Jensen medium, which provides the necessary nutrients for its slow growth over several weeks.</span></p>",
    "correct_choice_id": 291461,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13995,
    "choices": [
      {
        "id": 55941,
        "text": "<p><span style=\"font-size:12.0pt;\">All zone 1 injury to be treated conservatively</span></p>"
      },
      {
        "id": 55942,
        "text": "<p><span style=\"font-size:12.0pt;\">Zone 3 injury whether blunt or penetrative should always be explored</span></p>"
      },
      {
        "id": 55943,
        "text": "<p><span style=\"font-size:12.0pt;\">Zone 2 injury with expanding hematoma should be treated surgically</span></p>"
      },
      {
        "id": 55944,
        "text": "<p><span style=\"font-size:12.0pt;\">Mattox maneuver is when the ascending colon is mobilized to the right to visualise the Aorta</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Identify the true statement regarding retroperitoneal trauma? (AIIMS MAY 2020)</span></p>",
    "unique_key": "Q3769151",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449094,
    "difficulty_level": "intermediate",
    "subjects_id": [
      12
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Zone 2 injury with expanding hematoma should be treated surgically</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Zone 2 hematoma is seen in flank region and typically related to renal injury. Zone 2 hematomas may be conserved unless they are expanding, when surgery is indicated.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. All zone 1 injury to be treated conservatively</strong>: Zone 1 hematoma refers to central zone, where likely structures injured are abdominal aorta or IVC are injured. Since these are major vascular injuries, all zone 1 hematomas should be explored.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>Zone 3 injury whether blunt or penetrative should always be explored</strong>: Zone 3 refers to the pelvis region, and injuries in this area Should be managed conservatively with pelvic binder or external fixator. Exploration in these areas is dangerous and should be avoided whenever possible.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Mattox maneuver is when the ascending colon is mobilized to the right to visualise the Aorta</strong>: The Mattox maneuver is a surgical technique used during emergency laparotomies to visualize the abdominal aorta. It involves mobilizing the left sided abdominal viscera medially, which allows for better visualization of the retroperitoneum and the aorta. This maneuver can be useful in cases of trauma or other emergency situations where visualization of the aorta is necessary.</span></p>",
    "correct_choice_id": 55943,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 3408,
    "choices": [
      {
        "id": 13611,
        "text": "<p><span style=\"font-size:12.0pt;\">Hepatitis virus</span></p>"
      },
      {
        "id": 13612,
        "text": "<p><span style=\"font-size:12.0pt;\">Influenza virus</span></p>"
      },
      {
        "id": 13613,
        "text": "<p><span style=\"font-size:12.0pt;\">HIV</span></p>"
      },
      {
        "id": 13614,
        "text": "<p><span style=\"font-size:12.0pt;\">Herpes virus</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following organisms is represented by the given form of replication? (INICET MAY 2018)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/1-micro-12.jpg\" alt=\"\" width=\"700\" height=\"489\"></span></p>",
    "unique_key": "Q6349132",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449085,
    "difficulty_level": "beginner",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Influenza virus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given image shows the replication of influenza virus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Stages of replication:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Replication of influenza A viruses in the lung epithelium.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Binding of haemagglutinin (HA</strong>), expressed on the surface of the influenza virion, <strong>with sialic acid</strong> <strong>residues</strong> linked to cell surface glycans induces binding and fusion of the virion with the plasma membrane of the target cell.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The virus then enters the cell via endocytosis or micropinocytosis and is trafficked to the lysosome where acidification activates the proton selective matrix protein-2 viral channel (M2), inducing membrane fusion and dissociation of the viral ribonucleoprotein (RNP) core, which is then <strong>transported to the nucleus where viral RNA replication occurs</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Progeny viral RNP cores are generated in the cytosol and, with the viral surface proteins, HA and neuraminidase (NA), and other viral proteins, are concentrated in and near lipid rafts at the plasma membrane.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Budding of these plasma membrane regions forms complete viral progeny, which is linked to the plasma membrane by HA/sialic acid interactions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cleavage of sialic acid residues by neuraminidase releases the viral progeny so they are then free to infect other cells, which can be prevented by NA inhibitors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hepatitis virus:</strong> Hepatitis viruses have different replication mechanisms and do not exhibit the specific stages shown in the image for influenza virus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. HIV:</strong> HIV is a retrovirus that integrates its RNA into the host DNA using reverse transcriptase, followed by integration into the host genome, which is not depicted in the given image.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Herpes virus:</strong> Herpes viruses have a different replication mechanism involving DNA replication within the nucleus and the formation of nucleocapsids in the nucleus, not shown in the given image.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The replication cycle depicted in the image is characteristic of the influenza virus, involving binding of hemagglutinin (HA) to sialic acid residues, endocytosis, acidification within lysosomes, RNA replication in the nucleus, assembly at the plasma membrane, and release mediated by neuraminidase.</span></p>",
    "correct_choice_id": 13612,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74754,
    "choices": [
      {
        "id": 297925,
        "text": "<p><span style=\"font-size:16px;\">1 year</span></p>"
      },
      {
        "id": 297926,
        "text": "<p><span style=\"font-size:16px;\">2 years</span></p>"
      },
      {
        "id": 297927,
        "text": "<p><span style=\"font-size:16px;\">3 years</span></p>"
      },
      {
        "id": 297928,
        "text": "<p><span style=\"font-size:16px;\">4 years</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">A child who can make a cross, tell stories make tower of 6 cubes and goes to toilet alone, what is the age of the child: (INICET NOV 2024)</span></p>",
    "unique_key": "Q5996623",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449083,
    "difficulty_level": "intermediate",
    "subjects_id": [
      13
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) 4 years</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Child development follows predictable patterns across various domains including fine motor, gross motor, social, language, and self-care skills. The developmental milestones of the child's age:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\"><strong>Making a cross</strong>: This is a fine motor skill typically achieved around 4 years of age. A cross has four components, making it more complex than simpler shapes like circles (3 years) or vertical lines (2 years).</span></li><li><span style=\"font-size:16px;\"><strong>Telling stories/poems:</strong> This language and cognitive skill emerges around 4 years of age when children develop more complex narrative abilities and can recount events in sequence.</span></li><li><span style=\"font-size:16px;\"><strong>Making a tower of 6 cubes:</strong> Fine motor skills for stacking develop progressively. By 2 years, children can typically build a tower of 6 cubes (using the formula age \u00d7 3 = number of cubes).</span></li><li><span style=\"font-size:16px;\"><strong>Going to toilet alone:</strong> Complete toilet independence, including managing clothing and hygiene without assistance, is typically achieved by 4 years of age.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\">While some of these skills (like building a tower of 6 cubes) may be achieved earlier, the combination of all these milestones, particularly making a cross and independent toileting, points to <strong>a 4-year-old child.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. 1 year:</strong> At this age, children are developing basic motor skills like walking, may say a few words, and are nowhere near toilet independence. They cannot make crosses, tell stories, or build tall towers.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. 2 years:</strong> Children at this age can typically build a tower of 6 cubes, but cannot yet draw crosses, tell coherent stories, or manage toileting independently.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. 3 years:</strong> Three-year-olds may be developing toilet skills but typically still need some assistance. They can usually draw circles but not yet crosses, and their storytelling abilities are still developing.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The developmental milestones of a 4-year-old child, including the ability to draw a cross, tell stories, build a tower of 6 cubes, and achieve complete toilet independence.</span></p>",
    "correct_choice_id": 297928,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 54538,
    "choices": [
      {
        "id": 217621,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased formation of Heinz body</span></span></span></p>"
      },
      {
        "id": 217622,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Males and females can be affected</span></span></span></p>"
      },
      {
        "id": 217623,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Reduced NADPH</span></span></span></p>"
      },
      {
        "id": 217624,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Reduced oxidative stress inside the red cells</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following is not correct about a patient with G6PD deficiency?&nbsp;</span></span></span>&nbsp;(INICET MAY 2024)</p>",
    "unique_key": "Q3377348",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449099,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D) Reduced oxidative stress inside the red cells</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked recessive disorder that affects the red blood cells&#39; ability to handle oxidative stress.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is incorrect. G6PD deficiency actually increases oxidative stress inside red blood cells because the reduced NADPH levels lead to a decrease in reduced glutathione. This makes the cells more susceptible to oxidative damage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Increased formation of Heinz body</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Correct because this is a hallmark of G6PD deficiency due to oxidative damage to hemoglobin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Males and females can be affected</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Correct; while males are more commonly affected, females can also be affected due to the X-linked inheritance pattern.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Reduced NADPH</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Correct because this is a direct consequence of G6PD deficiency as the enzyme is essential for NADPH production in red blood cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">G6PD deficiency increases oxidative stress in red blood cells, leading to hemolysis and formation of Heinz bodies. It affects both males and females, though more commonly males.</span></span></span></p>",
    "correct_choice_id": 217624,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 43268,
    "choices": [
      {
        "id": 172739,
        "text": "<p><span style=\"font-size:12pt;\">EDTA</span></p>"
      },
      {
        "id": 172740,
        "text": "<p><span style=\"font-size:12pt;\">B.A.L</span></p>"
      },
      {
        "id": 172741,
        "text": "<p><span style=\"font-size:12pt;\">Desferrioxamine</span></p>"
      },
      {
        "id": 172742,
        "text": "<p><span style=\"font-size:12pt;\">Oximes</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not used in chelation of heavy metals: (</span>INICET Nov 2023)</p>",
    "unique_key": "Q1642184",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449070,
    "difficulty_level": "beginner",
    "subjects_id": [
      10
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D. Oximes</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Oximes, like pralidoxime, are specifically used to reactivate acetylcholinesterase inhibited by organophosphates and are not effective for heavy metal chelation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A</strong>. <strong>EDTA (Ethylenediaminetetraacetic acid):&nbsp;</strong>Used for chelation of heavy metals such as lead and cadmium.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. B.A.L (British Anti-Lewisite or Dimercaprol):&nbsp;</strong>Used for chelation of heavy metals such as lead, arsenic, and mercury.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Desferrioxamine:&nbsp;</strong>Specifically used for chelation of iron.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective :</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/screenshot-2024-05-08-100202.JPG\" alt=\"\" width=\"1000\" height=\"331\"></strong></span></p>",
    "correct_choice_id": 172742,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 4086,
    "choices": [
      {
        "id": 16323,
        "text": "<p><span style=\"font-size:12.0pt;\">Strongyloides stercoralis</span></p>"
      },
      {
        "id": 16324,
        "text": "<p><span style=\"font-size:12.0pt;\">Enterobius vermicularis</span></p>"
      },
      {
        "id": 16325,
        "text": "<p><span style=\"font-size:12.0pt;\">Ancylostoma duodenale</span></p>"
      },
      {
        "id": 16326,
        "text": "<p><span style=\"font-size:12.0pt;\">Ascaris lumbricoides</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Identify the organism shown in this image: (INICET NOV 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/8.jpg\" alt=\"\" width=\"300\" height=\"199\"></span></p>",
    "unique_key": "Q3815115",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449096,
    "difficulty_level": "beginner",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Ascaris lumbricoides</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The roundworm, <strong>Ascaris lumbricoides is the largest nematode parasite in the human intestine</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">They are large cylindrical worms with tapered ends</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The anterior end is more pointed than the posterior.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">They are pale pink or flesh colored when freshly passed in stools, but become white outside the body.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The mouth at the anterior end has three finely toothed lips, one dorsal and two ventrolateral</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Habitat - Small intestine (85% in the jejunum</strong> and 15% in the ileum).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Natural host \u2013 Man</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Infective form \u2013 embryonated eggs&nbsp;</strong>containing infective rhabditiform larvae</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mode of transmission \u2013 <strong>feco-oral route</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Disease caused by A. lumbricoides is called as ascariasis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Strongyloides stercoralis:</strong> Causes strongyloidiasis, and the worms are much smaller and typically not as robust as those shown in the image.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Enterobius vermicularis:</strong> Causes enterobiasis or pinworm infection. The worms are much smaller and thinner, typically only a few millimeters long.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Ancylostoma duodenale:</strong> Causes hookworm infection. The worms are also smaller and have a characteristic hook shape at one end.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><i>Ascaris lumbricoides</i> is a large, cylindrical nematode parasite found in the human intestine, easily identifiable by its size, tapered ends, and characteristic pink to white color transition. The disease it causes, ascariasis, is transmitted via the fecal-oral route.</span></p>",
    "correct_choice_id": 16326,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11645,
    "choices": [
      {
        "id": 46546,
        "text": "<p><span style=\"font-size:12.0pt;\">Muscle fatigue</span></p>"
      },
      {
        "id": 46547,
        "text": "<p><span style=\"font-size:12.0pt;\">Absent deep tendon reflexes</span></p>"
      },
      {
        "id": 46548,
        "text": "<p><span style=\"font-size:12.0pt;\">Normal pupillary reflex</span></p>"
      },
      {
        "id": 46549,
        "text": "<p><span style=\"font-size:12.0pt;\">Ptosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">What is not a feature of myasthenia gravis among the following? (AIIMS NOV 2017)</span></p>",
    "unique_key": "Q6229356",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449288,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Absent deep tendon reflexes.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Myasthenia gravis is an autoimmune neuromuscular disorder characterized by weakness and fatiguability of skeletal muscles. There is decrease in number of available acetylcholine receptors at neuromuscular junction due to an antibody mediated autoimmune attack.</span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Visual problems, including drooping eyelids (ptosis) and double vision (diplopia)</span></li><li><span style=\"color:black;font-size:12.0pt;\">Muscle weakness and fatigue may vary rapidly in intensity over days or even hours and worsen as muscles are used (early fatigue)</span></li><li><span style=\"color:black;font-size:12.0pt;\">Facial muscle involvement causing a mask-like appearance; a smile may appear more like a snarl</span></li><li><span style=\"color:black;font-size:12.0pt;\">Trouble swallowing or pronouncing words</span></li><li><span style=\"color:black;font-size:12.0pt;\">Weakness of the neck or limbs</span></li><li><span style=\"color:black;font-size:12.0pt;\">Weakness increases during repeated use or late in the day and may improve following rest or sleep.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Deep tendon reflexes preserved.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Muscle fatigue:</strong> This is a defining symptom of MG, characterized by increased muscle weakness with continued activity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Normal pupillary reflex:</strong> MG primarily affects voluntary muscles and typically does not impact the autonomic functions, including pupillary reflexes which remain normal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Ptosis:</strong> Ptosis, or drooping eyelids, is one of the common features of MG due to muscle weakness affecting the muscles that control eyelid elevation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Deep tendon reflexes are preserved in myasthenia gravis despite significant muscle weakness and fatigability, distinguishing it from other neuromuscular disorders that might also lead to reflex abnormalities.</span></p>",
    "correct_choice_id": 46547,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13778,
    "choices": [
      {
        "id": 55073,
        "text": "<p><span style=\"font-size:12.0pt;\">Deep branch of ulnar nerve</span></p>"
      },
      {
        "id": 55074,
        "text": "<p><span style=\"font-size:12.0pt;\">Median Nerve</span></p>"
      },
      {
        "id": 55075,
        "text": "<p><span style=\"font-size:12.0pt;\">Posterior interosseous nerve</span></p>"
      },
      {
        "id": 55076,
        "text": "<p><span style=\"font-size:12.0pt;\">Anterior interosseous nerve</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Loss of flexion at the interphalangeal joint of thumb after supracondylar fracture is due to the involvement of? (</span>AIIMS May 2018)</p>",
    "unique_key": "Q7398710",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449299,
    "difficulty_level": "intermediate",
    "subjects_id": [
      3
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Anterior interosseous nerve</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Loss of flexion at the interphalangeal (IP) joint of the thumb, is due to the involvement of the anterior interosseous nerve (AIN). This is a branch of the median nerve. It runs down the forearm along with the anterior interosseous artery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It supplies the deep muscles of the anterior (flexor) compartment of the forearm. Specifically, it provides innervation to the flexor pollicis longus (which flexes the interphalangeal joint of the thumb), the radial half of the flexor digitorum profundus, and the pronator quadratus. Injury to this nerve can lead to the inability to flex the interphalangeal joint of the thumb and the distal phalanges of the index and middle fingers, leading to the characteristic \"pinch sign\" or \"OK sign\" presentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/ia-11.jpg\" alt=\"\" width=\"300\" height=\"497\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Deep Branch of Ulnar Nerve</strong>: It arises from the ulnar nerve after it passes the flexor retinaculum in the wrist. The deep branch is mainly motor in function.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">This nerve supplies the hypothenar muscles (muscles of the little finger), the ulnar two lumbricals, all the interossei (both palmar and dorsal), and adductor pollicis. It does not have any role in the flexion of the interphalangeal joint of the thumb.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Median Nerve</strong>: This nerve originates from both the medial and lateral cords of the brachial plexus. It travels down the arm and forearm and goes through the carpal tunnel at the wrist.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">It supplies most of the flexors in the forearm and several muscles in the hand, including the thenar muscles (muscles of the thumb). But the flexion at the interphalangeal joint of the thumb is more specifically due to the anterior interosseous branch of the median nerve, not the main trunk of the median nerve.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Posterior Interosseous Nerve</strong>: It is a continuation of the deep branch of the radial nerve. It travels in the forearm between the superficial and deep layers of muscles.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">This nerve supplies the extensor muscles of the wrist and fingers. It's not involved in flexion movements and hence, not responsible for the flexion of the interphalangeal joint of the thumb.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Flexion of thumb occurs at 2 joints:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">IP joint: Flexor pollicis longs (FPL) supplied by the anterior interosseous nerve (a branch of the median nerve, C7 and C8).</span></li><li><span style=\"font-size:12.0pt;\">MCP joint: Flexor pollicis brevis (FPB supplied by the recurrent motor branch of the median nerve.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Most commonly injured nerve in SCH fracture: <strong>AIN &gt; Median &gt; Radial &gt; Ulnar (AMRU)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Deep branch of ulnar nerve \u2192 ulnar claw hand</span></li><li><span style=\"font-size:12.0pt;\">Posterior interosseous nerve \u2192 innervates the extensor muscles of the wrist and fingers. Weakness or paralysis of these muscles can cause difficulty in extending the wrist and fingers</span></li></ul>",
    "correct_choice_id": 55076,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14124,
    "choices": [
      {
        "id": 56457,
        "text": "<p><span style=\"font-size:12.0pt;\">USG abdomen</span></p>"
      },
      {
        "id": 56458,
        "text": "<p><span style=\"font-size:12.0pt;\">IV fluids</span></p>"
      },
      {
        "id": 56459,
        "text": "<p><span style=\"font-size:12.0pt;\">Exploratory laparotomy</span></p>"
      },
      {
        "id": 56460,
        "text": "<p><span style=\"font-size:12.0pt;\">Elective surgery</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A man in his 50s comes to the emergency room with severe abdominal pain. During the examination, his heart rate is 120 beats per minute, and his blood pressure is measured at 90/50mmg. Guarding is observed during a per abdomen examination. An erect abdominal X-ray is provided. What is the best management in this case based on these findings? (AIIMS NOV 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/04/untitled-190.jpg\" alt=\"\" width=\"300\" height=\"332\"></span></p>",
    "unique_key": "Q6510713",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449091,
    "difficulty_level": "beginner",
    "subjects_id": [
      12
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Exploratory laparotomy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Given clinical scenario of tachycardia, hypotension with abdominal guarding and X ray showing pneumoperitoneum is suggestive of hollow viscous perforation. The best management would be laparotomy and repair. The next step would be IV fluids.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given the patient's severe abdominal pain, guarding during the physical examination, tachycardia, and hypotension, along with X ray findings suggest a perforation. An exploratory laparotomy would allow for direct visualization and treatment of the underlying cause. In emergent situations like this, a surgical exploration might be the most appropriate next step. Hence, OPTION C is the most appropriate choice among the given options.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. USG abdomen:&nbsp;</strong>Ultrasonography (USG) of the abdomen is a non-invasive imaging technique used to visualize abdominal organs. It may be used for a preliminary assessment of abdominal pain, but in the case of a patient with severe pain, hemodynamic instability (as indicated by tachycardia and hypotension), and guarding, accompanied by X ray showing free air, a USG would not add to the management.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. IV fluids</strong>: Administering IV fluids can help stabilize the patient's blood pressure and is an essential immediate measure. However, fluids alone might not address the underlying cause of perforation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Elective surgery</strong>: Elective surgery is a planned procedure that is done when a condition is not immediately life-threatening. Given the severity of the patient's symptoms and the potential for an acute abdominal catastrophe, waiting for an elective procedure is not appropriate in this situation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Pneumoperitoneum&nbsp;</strong>refers to the presence of air or gas within the peritoneal cavity, the space within the abdomen that contains the intestines, liver, and other abdominal organs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Clinical Presentation and Diagnosis:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Patients with a significant amount of free air in the peritoneal cavity due to organ perforation often present with severe abdominal pain, signs of peritonitis (like guarding and rebound tenderness), and systemic symptoms like fever or shock. An erect abdominal X-ray is a commonly used diagnostic modality to detect pneumoperitoneum. On the X-ray, free air under the diaphragm, or \"free subdiaphragmatic air\", is a classic finding.</span></p>",
    "correct_choice_id": 56459,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11457,
    "choices": [
      {
        "id": 45794,
        "text": "<p><span style=\"font-size:12.0pt;\">Check blood sugar level</span></p>"
      },
      {
        "id": 45795,
        "text": "<p><span style=\"font-size:12.0pt;\">Give oral antihypertensive</span></p>"
      },
      {
        "id": 45796,
        "text": "<p><span style=\"font-size:12.0pt;\">IV mannitol</span></p>"
      },
      {
        "id": 45797,
        "text": "<p><span style=\"font-size:12.0pt;\">CT brain</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">An elderly diabetic and hypertensive patient was carried to the emergency room in a comatose state. On examination, the blood pressure was 170/100 mmHg and pulse rate were &gt;100/min. Plantar reflex was bilateral extensor. What is the next step to do? (</span>AIIMS May 2018)</p>",
    "unique_key": "Q1939263",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449102,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Check Blood sugar level</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Evaluation of Common reversible emergency causes are targeted in the ER. Altered mental status occurring acutely can be remembered with MIST.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Step 1.</strong> Rx &gt;&gt;&gt; Dx priority (\u2193 Glucose).</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture52.jpg\" alt=\"\" width=\"1000\" height=\"389\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;</strong>HTN emergency is treated with I.V. antihypertensives.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp;</strong>I.V. mannitol is used in the management of cerebral edema.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;</strong>CT brain to be done after ruling out life-threatening reversible common causes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The initial management of any comatose patient, particularly those with diabetes, should include rapid assessment of blood glucose levels to rule out hypo- or hyperglycemia as a reversible cause of the coma. This immediate action can be life-saving and should precede other investigations and treatments.</span></p>",
    "correct_choice_id": 45794,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 63419,
    "choices": [
      {
        "id": 252893,
        "text": "<p><span style=\"font-size:12.0pt;\">Wintrobe tube</span></p>"
      },
      {
        "id": 252894,
        "text": "<p><span style=\"font-size:12.0pt;\">WBC Pipette</span></p>"
      },
      {
        "id": 252895,
        "text": "<p><span style=\"font-size:12.0pt;\">RBC Pipette</span></p>"
      },
      {
        "id": 252896,
        "text": "<p><span style=\"font-size:12.0pt;\">Hemoglobin pipette</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Rees and Ecker diluting fluid is used in _______?</span></p>",
    "unique_key": "Q4108719",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449072,
    "difficulty_level": "intermediate",
    "subjects_id": [
      2
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) RBC Pipette</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Rees and Ecker's solution is used as a diluting fluid in the&nbsp;<strong>RBC pipette</strong> for performing&nbsp;<strong>platelet counts</strong>. Its composition includes:</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Components and Values:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Sodium citrate: 3.8 g</span></li><li><span style=\"font-size:16px;\">Formaldehyde (40%): 0.2 ml</span></li><li><span style=\"font-size:16px;\">Brilliant cresyl blue: 0.1 g</span></li><li><span style=\"font-size:16px;\">Distilled water: 100 ml</span></li></ul><p>&nbsp;</p><h3><span style=\"font-size:16px;\">Steps Involved in Platelet Count:</span></h3><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\"><strong>Filling the pipette</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">The diluting fluid is drawn to mark 1 of the RBC pipette and expelled.</span></li><li><span style=\"font-size:16px;\">Blood is aspirated to 0.5 mark of the RBC diluting pipette.</span></li><li><span style=\"font-size:16px;\">Diluting fluid is aspirated to the 101 mark.</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Wintrobe tube</strong>: Incorrect. The Wintrobe tube is used in the determination of erythrocyte sedimentation rate (ESR) and hematocrit values.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. WBC Pipette</strong>: Incorrect. The WBC pipette is used with other diluting fluids specific for leukocyte counts, not Rees and Ecker's fluid.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Hemoglobin pipette</strong>: Incorrect. Hemoglobin pipettes are used for hemoglobin estimation, typically not requiring Rees and Ecker's solution.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:16px;\">Rees and Ecker\u2019s solution is specifically used in the&nbsp;<strong>RBC pipette</strong> to dilute blood samples for accurate&nbsp;<strong>platelet counting</strong>.</span></p>",
    "correct_choice_id": 252895,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74849,
    "choices": [
      {
        "id": 298297,
        "text": "<p><span style=\"font-size:16px;\">Posterior auricular artery</span></p>"
      },
      {
        "id": 298298,
        "text": "<p><span style=\"font-size:16px;\">Middle meningeal artery</span></p>"
      },
      {
        "id": 298299,
        "text": "<p><span style=\"font-size:16px;\">Superficial temporal artery</span></p>"
      },
      {
        "id": 298300,
        "text": "<p><span style=\"font-size:16px;\">Occipital artery</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Identify the artery marked with blue arrow in the image.&nbsp;</span><span style=\"font-size:16px;\">(INICET NOV 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-19%20165703.jpg\" width=\"433\" height=\"416\"></span></p>",
    "unique_key": "Q3084544",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449103,
    "difficulty_level": "intermediate",
    "subjects_id": [
      17
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Superficial temporal artery</strong></span></p><p><br><span style=\"font-size:16px;\">The given image is from an MR angiography study showing vascular structures. The superficial temporal artery (STA) is a terminal branch of the external carotid artery (ECA) and runs laterally along the temples. It is a prominent artery that can be easily visualized in imaging. The superficial temporal artery is a direct continuation of the external carotid and is one of its terminal branches.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Posterior auricular artery:</strong> A smaller branch of the external carotid artery, located behind the ear, making it unlikely to be the identified artery.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Middle meningeal artery:</strong> A branch of the maxillary artery, which runs intracranially and supplies the meninges; not a direct division of the external carotid seen superficially.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Occipital artery:</strong> A branch of the external carotid artery that supplies the posterior scalp; it is not a lateral terminal branch like the STA.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p><br><span style=\"font-size:16px;\">The superficial temporal artery is a terminal branch of the external carotid artery, supplying the temporal region and easily identifiable in MR angiography studies.</span></p>",
    "correct_choice_id": 298299,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44017,
    "choices": [
      {
        "id": 175727,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oral contraceptive pills (OCPs)</span></span></span></p>"
      },
      {
        "id": 175728,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Functional ovarian cyst</span></span></span></p>"
      },
      {
        "id": 175729,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nulliparity</span></span></span></p>"
      },
      {
        "id": 175730,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polycystic ovary syndrome (PCOS)</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is a risk factor for progression to borderline ovarian tumor?</span></span>&nbsp;(INICET NOV 2023)</p>",
    "unique_key": "Q4629286",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449093,
    "difficulty_level": "intermediate",
    "subjects_id": [
      14
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Nulliparity</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nulliparity is associated with a slightly increased risk of ovarian tumors, including borderline ovarian tumors, possibly due to uninterrupted ovulation and hormonal fluctuations.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Oral contraceptive pills (OCPs:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Oral contraceptive pills (OCPs) are known to reduce the risk of ovarian cancer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Functional ovarian cyst:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Functional ovarian cysts typically do not progress to ovarian tumors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Polycystic ovary syndrome (PCOS):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Polycystic ovary syndrome (PCOS) has not been strongly linked with increased risk of borderline ovarian tumors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nulliparity is recognized as a risk factor for borderline ovarian tumors, highlighting the influence of reproductive factors on ovarian health.</span></span></span></p>",
    "correct_choice_id": 175729,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13118,
    "choices": [
      {
        "id": 52434,
        "text": "<p><span style=\"font-size:12.0pt;\">Choroiditis</span></p>"
      },
      {
        "id": 52435,
        "text": "<p><span style=\"font-size:12.0pt;\">\ufeff\ufeff\ufeffChloroquine toxicity</span></p>"
      },
      {
        "id": 52436,
        "text": "<p><span style=\"font-size:12.0pt;\">\ufeff\ufeff\ufeffSteroid-induced glaucoma</span></p>"
      },
      {
        "id": 52437,
        "text": "<p><span style=\"font-size:12.0pt;\">\ufeff\ufeff\ufeffMacular edema</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old female patient with a history of chronic arthritis on treatment came with complaints of defective vision in both eyes. On examination, vision in RE = 6/12, LE = 6/18, IOP = 18 mmHg in both eyes, and the anterior segment was normal. The fundus examination and fundus fluorescein angiography (FFA) findings are shown in the figure. What is the probable diagnosis? (</span>AIIMS Nov 2018)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture10_tPi4IFH.jpg\" alt=\"\" width=\"400\" height=\"331\"></span></p>",
    "unique_key": "Q5160803",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449291,
    "difficulty_level": "beginner",
    "subjects_id": [
      8
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Chloroquine toxicity</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's history of taking medication for rheumatoid arthritis and fundus with a bull's eye sign, along with the FFA image showing increased fluorescence in the macular area and round-shaped blocked fluorescence in the central fovea, suggest likely chloroquine toxicity. Here are some key points about chloroquine toxicity:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Prolonged administration of chloroquine may lead to a keratopathy, myopathy, retinopathy, and optic neuropathy.</span></li><li><span style=\"font-size:12.0pt;\">Chloroquine retinopathy is a serous pigmentary degeneration of the retina that may result in vision loss.</span></li><li><span style=\"font-size:12.0pt;\">A mild pigmentary disturbance in the macular area causes visual field defects, particularly a central scotoma, and a characteristic \"bull's-eye\" retinal lesion that can be seen on fluorescein angiography.</span></li><li><span style=\"font-size:12.0pt;\">Eventually, there is a widespread retinal atrophy with pigment clumping and attenuated retinal vessels.</span></li><li><span style=\"font-size:12.0pt;\">Short-term use of chloroquine can produce blurring of vision and diplopia, which is reversible upon stopping the drug.</span></li><li><span style=\"font-size:12.0pt;\">Hydroxychloroquine has a lower risk of ocular toxicity than chloroquine, but it has a weaker anti-inflammatory effect.</span></li><li><span style=\"font-size:12.0pt;\">The maximum dose allowed for chloroquine is 6 mg/kg in 24 hours, while for hydroxychloroquine, it is 4.5 mg/kg. Hydroxychloroquine is more commonly used today at a dose of 300-400 mg/day.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Choroiditis:</strong> This condition usually presents with patches of inflammation in the choroid, which are not observed in the provided images.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Steroid-induced glaucoma:</strong> This would more typically involve elevated intraocular pressure and optic nerve changes, which were not reported in the patient's examination.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Macular edema:</strong> While this might also involve changes in the macular region, it generally does not present with the specific \"bull's eye\" pattern seen in chloroquine toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/whatsapp-image-2023-09-26-at-162632.jpeg\" alt=\"\" width=\"700\" height=\"803\"></span></p>",
    "correct_choice_id": 52435,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44830,
    "choices": [
      {
        "id": 178967,
        "text": "<p><span style=\"font-size:12pt;\">Drug A is competitive inhibitor and drug B is un-competitive inhibitor</span></p>"
      },
      {
        "id": 178968,
        "text": "<p><span style=\"font-size:12pt;\">Drug A is competitive inhibitor and drug B is non-competitive inhibitor</span></p>"
      },
      {
        "id": 178969,
        "text": "<p><span style=\"font-size:12pt;\">Drug A is non-competitive inhibitor and drug B is competitive inhibitor</span></p>"
      },
      {
        "id": 178970,
        "text": "<p><span style=\"font-size:12pt;\">Drug A is un-competitive inhibitor and drug B is competitive inhibitor</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Which of the following statements regarding the drugs shown in graph A and graph B is correct. (</span>INICET May 2024)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/22/screenshot-2024-05-22-155759.png\" alt=\"\" width=\"400\" height=\"160\"></p>",
    "unique_key": "Q9825503",
    "question_audio": null,
    "question_video": null,
    "map_id": 34449098,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans&nbsp;B) Drug A is competitive inhibitor and drug B is non-competitive inhibitor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">To determine the correct answer, let's analyze the Lineweaver-Burk plots and the types of enzyme inhibition they represent:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For non-competitive inhibitors, the lines intersect at the x-axis. This type of inhibitor decreases VmaxVmax\u200b without affecting KmKm\u200b.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Competitive Inhibition</strong>: On a Lineweaver-Burk plot, competitive inhibitors intersect with the no-inhibitor line at the y-axis. This is because competitive inhibitors increase the apparent KmKm\u200b (Michaelis constant) without affecting VmaxVmax\u200b (maximum velocity).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Uncompetitive Inhibition</strong>: Uncompetitive inhibitors result in parallel lines on the Lineweaver-Burk plot. They decrease both VmaxVmax\u200b and KmKm\u200b proportionally.</span>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Given the descriptions of the graphs:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Graph A</strong>: The lines meet at the y-axis, indicating competitive inhibition.</span></li><li><span style=\"font-size:12pt;\"><strong>Graph B</strong>: The lines start from the same point on the x-axis, indicating non-competitive inhibition.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Therefore, the correct answer is:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>B. Drug A is competitive inhibitor and drug B is non-competitive inhibitor</strong></span></p>",
    "correct_choice_id": 178968,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  }
];
        let quizName = 'Late Night Pyq (Inicet, Mixed Bag-17)';
        const quizFilename = 'late-night-pyq-inicet-mixed-bag-17-060fa120.html';
        let hierarchy = ["Cerebellum", "Mock Test", "Late Night PYQ (INICET)"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        // --- NEW: History Management ---
        function saveProgress() {
            if (isQuizCompleted) return; // Don't save after completion
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            userHistory[quizFilename] = {
                questionStates,
                stats,
                currentQuestionIndex,
                currentMode,
                status: 'incomplete',
                lastSeen: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }

        function loadProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const savedState = userHistory[quizFilename];
            if (savedState) {
                questionStates = savedState.questionStates;
                stats = savedState.stats;
                currentQuestionIndex = savedState.currentQuestionIndex;
                currentMode = savedState.currentMode;
                console.log('Progress loaded.');
                return true;
            }
            return false;
        }

        function clearProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            if(userHistory[quizFilename]) {
                delete userHistory[quizFilename];
                localStorage.setItem('userHistory', JSON.stringify(userHistory));
                console.log('Previous progress cleared.');
            }
        }

        function markQuizAsCompleted() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const totalQuestions = questionsData.length;
            const correct = stats.correctAnswers || 0;
            
            userHistory[quizFilename] = {
                score: correct,
                total: totalQuestions,
                status: 'completed',
                completedOn: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }
        // --- End of History Management ---

        const urlParams = new URLSearchParams(window.location.search);
        const startAt = parseInt(urlParams.get('startAt'));
        const resume = urlParams.get('resume') === 'true';

        function goBack() {
            if (!isQuizCompleted) saveProgress(); // Save progress before leaving
            window.location.href = document.referrer || 'index.html';
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            if (!isNaN(startAt) && startAt >= 0 && startAt < questionsData.length) {
                currentQuestionIndex = startAt;
            }

            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                processAnswer();
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
            saveProgress(); // NEW: Save on navigation
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            showSolution();
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            stats.correctAnswers = correct; // Update global stats
            stats.incorrectAnswers = incorrect;
            markQuizAsCompleted(); // NEW: Mark quiz as complete in history
            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                clearProgress(); // NEW: Clear history on retake
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                        saveProgress();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (resume) {
                if (loadProgress()) {
                    document.getElementById('modeModal').style.display = 'none';
                    initializeQuiz(); // Resume directly into the saved mode and state
                } else {
                    // If resume fails (e.g., cleared history), start fresh
                    clearProgress();
                    document.getElementById('modeModal').style.display = 'flex';
                }
             } else if (!window.location.pathname.endsWith('custom_quiz.html')) {
                clearProgress(); // Clear old progress if not resuming
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>